Autosomal recessive
Monogenic disorders list based on single and multiple genes
Disorder Name (Total=311) | Aliases | Category | Gene | Indian Reports | Link |
---|---|---|---|---|---|
Farber lipogranulomatosis |
• Farber disease |
Metabolic disorders/Lysosomal storage disorders |
ASAH1 N-acylsphingosine amidohydrolase 1 |
Reports Updated as of Sep 15, 2022 |
PubMed |
Canavan disease |
• Spongy degeneration of central nervous system • Aspartoacylase deficiency • ACY2 deficiency • ASP deficiency • Aminoacylase 2 deficiency • Canavan-van Bogaert-Bertrand disease • Von Bogaert-Bertrand disease |
Neurodegenerative disorders |
ASPA aspartoacylase |
Reports Updated as of Sep 15, 2022 |
PubMed |
Ataxia-telangiectasia syndrome |
• Louis-Bar syndrome • Ataxia-telangiectasia • Ataxia-telangiectasia, complementation group D • Ataxia-telangiectasia, complementation group E • Cerebello-oculocutaneous telangiectasia • Immunodeficiency with ataxia telangiectasia |
Neurodegenerative disorders |
ATM ATM serine/threonine kinase |
Reports Updated as of Sep 15, 2022 |
PubMed |
Biotinidase deficiency |
• Juvenile-onset multiple carboxylase deficiency • Late-onset multiple carboxylase deficiency • Biotin deficiency • BTD deficiency • Late-onset biotin-responsive multiple carboxylase deficiency |
Metabolic disorders |
BTD biotinidase |
Reports Updated as of Sep 15, 2022 |
PubMed |
Diastrophic dysplasia |
• Diastrophic dwarfism |
Bone disorders |
SLC26A2 solute carrier family 26 member 2 |
Reports Updated as of Sep 15, 2022 |
PubMed |
Glycogen storage disease, type II |
• Pompe disease • Glycogen storage disease due to acid maltase deficiency |
Metabolic disorders/Lysosomal storage disorders |
GAA alpha glucosidase PIK3CA phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha |
Reports Updated as of Sep 15, 2022 |
PubMed |
Tay-Sachs disease |
• Hexosaminidase A deficiency • GM2 gangliosidosis, B, B1 variant • GM2 gangliosidosis, type 1 • HexA deficiency • Hexosaminidase alpha-subunit deficiency (variant B) • Sphingolipidosis, Tay-Sachs |
Metabolic disorders/Lysosomal storage disorders |
GM2A ganglioside GM2 activator HEXA hexosaminidase subunit alpha |
Reports Updated as of Sep 15, 2022 |
PubMed |
Alkaptonuria |
• Homogentisic acid oxidase deficiency • Hereditary ochronosis • Alkaptonuric ochronosis • Homogentisic acidura • Alcaptonuria • Ochronosis, hereditary |
Metabolic disorders |
HGD homogentisate 1,2-dioxygenase |
Reports Updated as of Sep 15, 2022 |
PubMed |
Phenylketonuria |
• Phenylalanine hydroxylase deficiency • Phenylketonurias • Folling disease • Oligophrenia phenylpyruvica |
Metabolic disorders |
PAH phenylalanine hydroxylase COL1A1 collagen type I alpha 1 chain |
Reports Updated as of Sep 15, 2022 |
PubMed |
Autosomal recessive polycystic kidney disease |
• AR polycystic kidney disease • Polycystic kidney disease, infantile type • AR-PKD |
Nephrological disorders |
PKHD1 PKHD1 ciliary IPT domain containing fibrocystin/polyductin PKD2 polycystin 2, transient receptor potential cation channel PKD1 polycystin 1, transient receptor potential channel interacting CYS1 cystin 1 |
Reports Updated as of Sep 15, 2022 |
PubMed |
Metaphyseal chondrodysplasia, McKusick type |
• Cartilage hair hypoplasia • Cartilage-hair hypoplasia • McKusick type |
Immune disorders |
RMRP RNA component of mitochondrial RNA processing endoribonuclease |
Reports Updated as of Sep 15, 2022 |
PubMed |
Niemann-Pick disease, type B |
• Chronic visceral acid sphingomyelinase deficiency |
Metabolic disorders/Lysosomal storage disorders |
SMPD1 sphingomyelin phosphodiesterase 1 |
Reports Updated as of Sep 15, 2022 |
PubMed |
Chorea-acanthocytosis |
• Levine-Critchley syndrome • Acanthocytosis with neurologic disorder • Choreaacanthocytosis • Choreoacanthocytosis • ChAc |
Neurodegenerative disorders |
VPS13A vacuolar protein sorting 13 homolog A |
Reports Updated as of Sep 15, 2022 |
PubMed |
Crigler-Najjar syndrome type 1 |
• Bilirubin uridinediphosphate glucuronosyltransferase deficiency type 1 • Bilirubin-UGT deficiency type 1 • Bilirubin |
Metabolic disorders |
UGT1A1 UDP glucuronosyltransferase family 1 member A1 |
Reports Updated as of Sep 15, 2022 |
PubMed |
Lethal osteosclerotic bone dysplasia |
• Raine syndrome • Raine syndrome • Osteosclerotic bone dysplasia |
Bone disorders |
FAM20C FAM20C golgi associated secretory pathway kinase |
Reports Updated as of Sep 15, 2022 |
PubMed |
Spinal muscular atrophy 1 |
• Werdnig-Hoffmann disease • Muscular atrophy, infantile • SMA I |
Neuromuscular disorders |
SMN1 survival of motor neuron 1, telomeric SMN2 survival of motor neuron 2, centromeric |
Reports Updated as of Sep 15, 2022 |
PubMed |
Adisons disease | Endocrine disorders |
PTPN22 protein tyrosine phosphatase non-receptor type 22 HLA-B major histocompatibility complex, class I, B HLA-DRB1 major histocompatibility complex, class II, DR beta 1 |
Reports Updated as of Mar 09, 2023 |
PubMed | |
Gaucher disease |
• Glucocerebrosidosis • Acute cerebral Gaucher disease • Glucocerebrosidase deficiency • Cerebroside lipidosis syndrome • Glucosyl cerebroside lipidosis • Glucosylceramidase deficiency • Kerasin lipoidosis • Kerasin thesaurismosis • Sphingolipidosis 1 • Gaucher splenomegaly • Acid beta-glucosidase deficiency |
Metabolic disorders/Lysosomal storage disorders |
GBA1 glucosylceramidase beta 1 PSAP prosaposin MSH6 mutS homolog 6 |
Reports Updated as of Mar 09, 2023 |
PubMed |
GM1 gangliosidosis type 2 |
• GM2 gangliosidosis |
Metabolic disorders/Lysosomal storage disorders |
GLB1 galactosidase beta 1 |
Reports Updated as of Mar 09, 2023 |
PubMed |
Celiac disease | Gastrointestinal disorders |
CTLA4 cytotoxic T-lymphocyte associated protein 4 HLA-DQA1 major histocompatibility complex, class II, DQ alpha 1 HLA-DQB1 major histocompatibility complex, class II, DQ beta 1 |
Reports Updated as of Mar 09, 2023 |
PubMed | |
Usher syndrome |
• Retinitis pigmentosa-deafness syndrome • Retinitis pigmentosa-hearing loss syndrome • Usher Syndromes • Usher's syndrome • USH |
Eye disorders / Ear disorders |
USH2A usherin WHRN whirlin USH1G USH1 protein network component sans CLRN1 clarin 1 CDH23 cadherin related 23 PCDH15 protocadherin related 15 USH1C USH1 protein network component harmonin ADGRV1 adhesion G protein-coupled receptor V1 MYO7A myosin VIIA HARS1 histidyl-tRNA synthetase 1 PDZD7 PDZ domain containing 7 CIB2 calcium and integrin binding family member 2 PROM1 prominin 1 ESPN espin ARSG arylsulfatase G SLC9B1 solute carrier family 9 member B1 |
Reports Updated as of Mar 09, 2023 |
PubMed |
Finnish congenital nephrotic syndrome |
• Congenital nephrotic syndrome • Finnish congenital nephrosis • Congenital nephrotic syndrome, Finnish type |
Nephrological disorders |
NPHS1 NPHS1 adhesion molecule, nephrin FAT1 FAT atypical cadherin 1 |
Reports Updated as of Mar 09, 2023 |
PubMed |
Autosomal recessive Robinow syndrome |
• Robinow syndrome |
Bone disorders |
ROR2 receptor tyrosine kinase like orphan receptor 2 |
Reports Updated as of Mar 09, 2023 |
PubMed |
Maple syrup urine disease |
• Branched-chain 2-ketoacid dehydrogenase deficiency • BCKD deficiency • BCKDH deficiency • Branched-chain ketoaciduria • MSUD |
Metabolic disorders |
BCKDHA branched chain keto acid dehydrogenase E1 subunit alpha BCKDHB branched chain keto acid dehydrogenase E1 subunit beta DBT dihydrolipoamide branched chain transacylase E2 |
Reports Updated as of Mar 09, 2023 |
PubMed |
Sudden infant death syndrome | Metabolic disorders |
KCNQ1 potassium voltage-gated channel subfamily Q member 1 KCNH2 potassium voltage-gated channel subfamily H member 2 SCN5A sodium voltage-gated channel alpha subunit 5 SCN4B sodium voltage-gated channel beta subunit 4 SCN1A sodium voltage-gated channel alpha subunit 1 DEPDC5 DEP domain containing 5, GATOR1 subcomplex subunit CALM2 calmodulin 2 |
Reports Updated as of Mar 09, 2023 |
PubMed | |
Lamellar ichthyosis | Skin disorders |
TGM1 transglutaminase 1 ABCA12 ATP binding cassette subfamily A member 12 SLC27A4 solute carrier family 27 member 4 NIPAL4 NIPA like domain containing 4 CYP4F22 cytochrome P450 family 4 subfamily F member 22 ALOX12B arachidonate 12-lipoxygenase, 12R type CERS3 ceramide synthase 3 PNPLA1 patatin like phospholipase domain containing 1 ALOXE3 arachidonate lipoxygenase 3 |
Reports Updated as of Mar 09, 2023 |
PubMed | |
CFH-Related dense deposit disease |
• Dense deposit disease |
Nephrological disorders |
CFHR5 complement factor H related 5 CFH complement factor H |
Reports Updated as of Mar 09, 2023 |
PubMed |
Acromesomelic dysplasia | Bone disorders |
BMPR1B bone morphogenetic protein receptor type 1B GDF5 growth differentiation factor 5 NPR2 natriuretic peptide receptor 2 ANK2 ankyrin 2 PRKG2 protein kinase cGMP-dependent 2 |
Reports Updated as of Mar 09, 2023 |
PubMed | |
Qualitative or quantitative defects of dysferlin |
• Dysferlinopathy |
Neuromuscular disorders |
DYSF dysferlin |
Reports Updated as of Mar 09, 2023 |
PubMed |
Deficiency of ferroxidase |
• Aceruloplasminemia • Hereditary ceruloplasmin deficiency |
Metabolic disorders |
CP ceruloplasmin |
Reports Updated as of Mar 09, 2023 |
PubMed |
Protein-losing enteropathy |
• Complement hyperactivation, angiopathic thrombosis, and protein-losing enteropathy [CHAPLE] • CHAPLE syndrome |
Gastrointestinal disorders |
CD55 CD55 molecule (Cromer blood group) |
Reports Updated as of Mar 09, 2023 |
PubMed |
Trimethylaminuria |
• Fish odor syndrome • Severe primary trimethylaminuria • TMAU |
Metabolic disorders |
FMO3 flavin containing dimethylaniline monoxygenase 3 |
Reports Updated as of Mar 09, 2023 |
PubMed |
Sjogren Syndrome |
• Sjögren’s Syndrome |
Immune disorders |
IRF5 interferon regulatory factor 5 |
Reports Updated as of Mar 09, 2023 |
PubMed |
Netherton syndrome | Skin disorders |
SPINK5 serine peptidase inhibitor Kazal type 5 |
Reports Updated as of Mar 09, 2023 |
PubMed | |
Cockayne syndrome | Neurodegenerative disorders |
ERCC6 ERCC excision repair 6, chromatin remodeling factor ERCC8 ERCC excision repair 8, CSA ubiquitin ligase complex subunit ERCC4 ERCC excision repair 4, endonuclease catalytic subunit |
Reports Updated as of Mar 09, 2023 |
PubMed | |
Achalasia cardia | Gastrointestinal disorders |
NOS1 nitric oxide synthase 1 VIP vasoactive intestinal peptide AAAS aladin WD repeat nucleoporin CRLF1 cytokine receptor like factor 1 |
Reports Updated as of Mar 09, 2023 |
PubMed | |
Camptodactyly-arthropathy-coxa vara-pericarditis syndrome | Bone disorders |
PRG4 proteoglycan 4 |
Reports Updated as of Mar 09, 2023 |
PubMed | |
Hyperammonemic encephalopathy due to carbonic anhydrase VA deficiency |
• CA-VA deficiency |
Metabolic disorders |
CA5A carbonic anhydrase 5A |
Reports Updated as of Mar 09, 2023 |
PubMed |
Cholestanol storage disease |
• Cerebrotendinous xanthomatosis • Cholestanolosis • Cerebral cholesterinosis |
Metabolic disorders/Lysosomal storage disorders |
CYP27A1 cytochrome P450 family 27 subfamily A member 1 |
Reports Updated as of Mar 09, 2023 |
PubMed |
Triglyceride storage disease with ichthyosis |
• Dorfman-Chanarin disease • Neutral Lipid Storage Disease With Ichthyosis |
Metabolic disorders/Lysosomal storage disorders |
ABHD5 abhydrolase domain containing 5, lysophosphatidic acid acyltransferase |
Reports Updated as of Mar 09, 2023 |
PubMed |
Spondyloepiphyseal dysplasia with congenital joint dislocations |
• CHST3-related skeletal dysplasia • Chondrodysplasia with congenital joint dislocations |
Bone disorders |
CHST3 carbohydrate sulfotransferase 3 |
Reports Updated as of Mar 09, 2023 |
PubMed |
Cystinosis |
• Protein defect of cystin transport • Cystine diathesis • Cystine disease • Cystine storage disease • Cystinoses |
Metabolic disorders/Lysosomal storage disorders |
CTNS cystinosin, lysosomal cystine transporter |
Reports Updated as of Mar 09, 2023 |
PubMed |
Multiple acyl-CoA dehydrogenase deficiency |
• Glutaric acidemia type 2 |
Metabolic disorders |
ETFDH electron transfer flavoprotein dehydrogenase ETFA electron transfer flavoprotein subunit alpha FLAD1 flavin adenine dinucleotide synthetase 1 ETFB electron transfer flavoprotein subunit beta MADD MAP kinase activating death domain |
Reports Updated as of Mar 09, 2023 |
PubMed |
Infantile GM1 gangliosidosis |
• GM1 gangliosidosis |
Metabolic disorders/Lysosomal storage disorders |
GLB1 galactosidase beta 1 |
Reports Updated as of Mar 09, 2023 |
PubMed |
Goldenhar syndrome | Bone disorders |
SF3B2 splicing factor 3b subunit 2 ZYG11B zyg-11 family member B, cell cycle regulator FOXI3 forkhead box I3 |
Reports Updated as of Mar 09, 2023 |
PubMed | |
Hurler syndrome |
• Mucopolysaccharidosis type ih • Gargoylism, hurler syndrome |
Metabolic disorders/Lysosomal storage disorders |
IDUA alpha-L-iduronidase PITX1 paired like homeodomain 1 |
Reports Updated as of May 24, 2023 |
PubMed |
Hyaline fibromatosis syndrome | Bone disorders |
ANTXR2 ANTXR cell adhesion molecule 2 |
Reports Updated as of May 24, 2023 |
PubMed | |
Mucolipidosis type II |
• I-Cell disease • I cell disease |
Metabolic disorders/Lysosomal storage disorders |
GNPTAB N-acetylglucosamine-1-phosphate transferase subunits alpha and beta |
Reports Updated as of May 24, 2023 |
PubMed |
Johanson-Blizzard syndrome | Developmental / Multisystemic disorders |
UBR1 ubiquitin protein ligase E3 component n-recognin 1 |
Reports Updated as of May 24, 2023 |
PubMed | |
Krabbe disease |
• Globoid cell leukodystrophy |
Metabolic disorders/Lysosomal storage disorders |
PSAP prosaposin |
Reports Updated as of May 24, 2023 |
PubMed |
Laurence-Moon syndrome | Eye disorders |
PNPLA6 patatin like phospholipase domain containing 6 |
Reports Updated as of May 24, 2023 |
PubMed | |
Leber congenital amaurosis | Eye disorders |
LCA5 lebercilin LCA5 CEP290 centrosomal protein 290 SPATA7 spermatogenesis associated 7 RDH12 retinol dehydrogenase 12 RPGRIP1 RPGR interacting protein 1 AIPL1 aryl hydrocarbon receptor interacting protein like 1 CRB1 crumbs cell polarity complex component 1 CRX cone-rod homeobox GUCY2D guanylate cyclase 2D, retinal RPE65 retinoid isomerohydrolase RPE65 RD3 RD3 regulator of GUCY2D IMPDH1 inosine monophosphate dehydrogenase 1 TULP1 TUB like protein 1 KCNJ13 potassium inwardly rectifying channel subfamily J member 13 NMNAT1 nicotinamide nucleotide adenylyltransferase 1 GDF6 growth differentiation factor 6 RIMS1 regulating synaptic membrane exocytosis 1 NPHP1 nephrocystin 1 LRAT lecithin retinol acyltransferase PDE6A phosphodiesterase 6A AHI1 Abelson helper integration site 1 RP2 RP2 activator of ARL3 GTPase IQCB1 IQ motif containing B1 TUBB4B tubulin beta 4B class IVb USP45 ubiquitin specific peptidase 45 PROM1 prominin 1 INPP5E inositol polyphosphate-5-phosphatase E CFAP410 cilia and flagella associated protein 410 ALMS1 ALMS1 centrosome and basal body associated protein RPGRIP1L RPGRIP1 like |
Reports Updated as of May 24, 2023 |
PubMed | |
Warburg micro syndrome |
• Micro syndrome |
Neurodevelopmental disorders |
RAB3GAP1 RAB3 GTPase activating protein catalytic subunit 1 RAB18 RAB18, member RAS oncogene family RAB3GAP2 RAB3 GTPase activating non-catalytic protein subunit 2 TBC1D20 TBC1 domain family member 20 |
Reports Updated as of Sep 05, 2023 |
PubMed |
Peroxisome biogenesis disorder |
• Neonatal adrenoleukodystrophy |
Neurodegenerative disorders |
PEX26 peroxisomal biogenesis factor 26 PEX16 peroxisomal biogenesis factor 16 PEX3 peroxisomal biogenesis factor 3 PEX10 peroxisomal biogenesis factor 10 PEX1 peroxisomal biogenesis factor 1 PEX14 peroxisomal biogenesis factor 14 PEX13 peroxisomal biogenesis factor 13 PEX12 peroxisomal biogenesis factor 12 PEX7 peroxisomal biogenesis factor 7 PEX6 peroxisomal biogenesis factor 6 PEX5 peroxisomal biogenesis factor 5 PEX2 peroxisomal biogenesis factor 2 PEX19 peroxisomal biogenesis factor 19 PEX11B peroxisomal biogenesis factor 11 beta |
Reports Updated as of Sep 05, 2023 |
PubMed |
Hypertrophic osteoarthropathy |
• Pachydermoperiostosis |
Bone disorders |
HPGD 15-hydroxyprostaglandin dehydrogenase SLCO2A1 solute carrier organic anion transporter family member 2A1 |
Reports Updated as of Sep 05, 2023 |
PubMed |
Persistent mullerian duct syndrome |
• Persistent Müllerian duct syndrome • PMDS • Persistent Müllerian derivatives |
Endocrine disorders |
AMH anti-Mullerian hormone AMHR2 anti-Mullerian hormone receptor type 2 |
Reports Updated as of Sep 05, 2023 |
PubMed |
Pontocerebellar hypoplasia type 1 | Neuromuscular disorders |
VRK1 VRK serine/threonine kinase 1 EXOSC3 exosome component 3 CLP1 cleavage factor polyribonucleotide kinase subunit 1 CHMP1A charged multivesicular body protein 1A |
Reports Updated as of Sep 05, 2023 |
PubMed | |
Progressive Pseudorheumatoid Dysplasia | Bone disorders |
CCN6 cellular communication network factor 6 |
Reports Updated as of Sep 05, 2023 |
PubMed | |
Rhizomelic chondrodysplasia punctata | Developmental / Multisystemic disorders |
AGPS alkylglycerone phosphate synthase GNPAT glyceronephosphate O-acyltransferase PEX7 peroxisomal biogenesis factor 7 PEX5 peroxisomal biogenesis factor 5 |
Reports Updated as of Sep 05, 2023 |
PubMed | |
Severe combined immunodeficiency due to DCLRE1C deficiency |
• SCID due to ARTEMIS deficiency |
Immune disorders |
DCLRE1C DNA cross-link repair 1C LIG4 DNA ligase 4 |
Reports Updated as of Sep 05, 2023 |
PubMed |
Sialidosis type 2 |
• Sialidase deficiency • Infantile dysmorphic sialidosis |
Metabolic disorders/Lysosomal storage disorders |
NEU1 neuraminidase 1 |
Reports Updated as of Sep 05, 2023 |
PubMed |
Spondylocostal dysostosis |
• Spondylothoracic dysostosis |
Bone disorders |
MESP2 mesoderm posterior bHLH transcription factor 2 DLL3 delta like canonical Notch ligand 3 LFNG LFNG O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase HES7 hes family bHLH transcription factor 7 TBX6 T-box transcription factor 6 RIPPLY2 ripply transcriptional repressor 2 |
Reports Updated as of Sep 05, 2023 |
PubMed |
Wilson disease | Metabolic disorders |
ATP7B ATPase copper transporting beta |
Reports Updated as of Sep 05, 2023 |
PubMed | |
Winchester syndrome | Bone disorders |
MMP14 matrix metallopeptidase 14 |
Reports Updated as of Sep 05, 2023 |
PubMed | |
Wolfram syndrome | Neurodegenerative disorders |
CISD2 CDGSH iron sulfur domain 2 WFS1 wolframin ER transmembrane glycoprotein |
Reports Updated as of Sep 05, 2023 |
PubMed | |
Bardet-Biedl syndrome | Eye disorders |
WDPCP WD repeat containing planar cell polarity effector SDCCAG8 SHH signaling and ciliogenesis regulator SDCCAG8 BBS12 Bardet-Biedl syndrome 12 BBS10 Bardet-Biedl syndrome 10 CEP290 centrosomal protein 290 TMEM67 transmembrane protein 67 MKS1 MKS transition zone complex subunit 1 ARL6 ADP ribosylation factor like GTPase 6 TTC8 tetratricopeptide repeat domain 8 BBS9 Bardet-Biedl syndrome 9 BBS7 Bardet-Biedl syndrome 7 BBS2 Bardet-Biedl syndrome 2 MKKS MKKS centrosomal shuttling protein BBS5 Bardet-Biedl syndrome 5 TRIM32 tripartite motif containing 32 BBS4 Bardet-Biedl syndrome 4 BBS1 Bardet-Biedl syndrome 1 CFAP418 cilia and flagella associated protein 418 LZTFL1 leucine zipper transcription factor like 1 BBIP1 BBSome interacting protein 1 IFT27 intraflagellar transport 27 IFT172 intraflagellar transport 172 IFT74 intraflagellar transport 74 TRAPPC3 trafficking protein particle complex subunit 3 CEP19 centrosomal protein 19 ALMS1 ALMS1 centrosome and basal body associated protein RPGRIP1L RPGRIP1 like TSPOAP1 TSPO associated protein 1 COMT catechol-O-methyltransferase |
Reports Updated as of Sep 05, 2023 |
PubMed | |
Friedreich ataxia | Neurodegenerative disorders |
FXN frataxin |
Reports Updated as of Sep 05, 2023 |
PubMed | |
Deficiency of galactokinase |
• Galactokinase deficiency • GALK deficiency • GALK-D |
Metabolic disorders |
GALK1 galactokinase 1 |
Reports Updated as of Sep 05, 2023 |
PubMed |
Galactose epimerase deficiency |
• UDP-galactose-4-epimerase deficiency • Uridine diphosphate galactose 4-epimerase deficiency • GALE deficiency |
Metabolic disorders |
GALE UDP-galactose-4-epimerase |
Reports Updated as of Sep 05, 2023 |
PubMed |
Galactosemia |
• Galactose-1-phosphate uridyl transferase deficiency |
Metabolic disorders |
GALT galactose-1-phosphate uridylyltransferase GALM galactose mutarotase |
Reports Updated as of Sep 05, 2023 |
PubMed |
Mucopolysaccharidosis, MPS-IV-A |
• GALNS deficiency |
Metabolic disorders/Lysosomal storage disorders |
GALNS galactosamine (N-acetyl)-6-sulfatase |
Reports Updated as of Sep 05, 2023 |
PubMed |
Mucopolysaccharidosis type 6 | Metabolic disorders/Lysosomal storage disorders |
ARSB arylsulfatase B GUSB glucuronidase beta |
Reports Updated as of Sep 05, 2023 |
PubMed | |
Hb SS disease |
• Sickle cell anemia |
Blood disorders |
HBB hemoglobin subunit beta |
Reports Updated as of Nov 02, 2023 |
PubMed |
Hyperphenylalaninemia due to tetrahydrobiopterin deficiency |
• Tetrahydrobiopterin deficiency • Hyperphenylalaninemia • Dihydropteridine reductase deficiency |
Metabolic disorders |
GCH1 GTP cyclohydrolase 1 |
Reports Updated as of Nov 02, 2023 |
PubMed |
Wolman disease |
• Lysosomal acid lipase deficiency • Acid lipase disease • Wolman disease with hypolipoproteinemia and acanthocytosis • LAL deficiency |
Metabolic disorders |
LIPA lipase A, lysosomal acid type |
Reports Updated as of Nov 02, 2023 |
PubMed |
Nephronophthisis | Nephrological disorders |
XPNPEP3 X-prolyl aminopeptidase 3 TMEM67 transmembrane protein 67 NEK8 NIMA related kinase 8 NPHP3 nephrocystin 3 NPHP4 nephrocystin 4 NPHP1 nephrocystin 1 WDR19 WD repeat domain 19 TTC21B tetratricopeptide repeat domain 21B CEP164 centrosomal protein 164 ANKS6 ankyrin repeat and sterile alpha motif domain containing 6 GLIS2 GLIS family zinc finger 2 CEP83 centrosomal protein 83 DCDC2 doublecortin domain containing 2 RPGRIP1L RPGRIP1 like IQCB1 IQ motif containing B1 INVS inversin MAPKBP1 mitogen-activated protein kinase binding protein 1 RBM48 RNA binding motif protein 48 INCENP inner centromere protein FAM186B family with sequence similarity 186 member B PIAS1 protein inhibitor of activated STAT 1 CEP290 centrosomal protein 290 ZNF423 zinc finger protein 423 AHI1 Abelson helper integration site 1 RMND1 required for meiotic nuclear division 1 homolog MKKS MKKS centrosomal shuttling protein SLC41A1 solute carrier family 41 member 1 ADAMTS9 ADAM metallopeptidase with thrombospondin type 1 motif 9 |
Reports Updated as of Nov 02, 2023 |
PubMed | |
xeroderma pigmentosum | Skin disorders |
XPC XPC complex subunit, DNA damage recognition and repair factor XPA XPA, DNA damage recognition and repair factor POLH DNA polymerase eta DDB2 damage specific DNA binding protein 2 ERCC5 ERCC excision repair 5, endonuclease ERCC4 ERCC excision repair 4, endonuclease catalytic subunit ERCC3 ERCC excision repair 3, TFIIH core complex helicase subunit ERCC2 ERCC excision repair 2, TFIIH core complex helicase subunit |
Reports Updated as of Nov 02, 2023 |
PubMed | |
Alpha-1-antitrypsin deficiency | Metabolic disorders |
SERPINA1 serpin family A member 1 |
Reports Updated as of Nov 02, 2023 |
PubMed | |
alpha Thalassemia |
• Alpha-thalassemia • A-Thalassemia |
Blood disorders |
ATRX ATRX chromatin remodeler HBA2 hemoglobin subunit alpha 2 HBA1 hemoglobin subunit alpha 1 |
Reports Updated as of Nov 10, 2023 |
PubMed |
Acrocallosal syndrome |
• Hallux duplication |
Bone disorders |
KIF7 kinesin family member 7 |
Reports Updated as of Nov 10, 2023 |
PubMed |
Alopecia universalis congenita |
• Universal alopecia • Alopecia areata |
Skin disorders |
HR HR lysine demethylase and nuclear receptor corepressor |
Reports Updated as of Nov 30, 2023 |
PubMed |
Arginase deficiency |
• Argininemia • Hyperargininemia |
Metabolic disorders |
ARG1 arginase 1 |
Reports Updated as of Nov 30, 2023 |
PubMed |
Acute fatty liver of pregnancy |
• LCHAD deficiency • Long chain 3-hydroxyacyl-CoA dehydrogenase deficiency • AFLP |
Metabolic disorders |
HADHA hydroxyacyl-CoA dehydrogenase trifunctional multienzyme complex subunit alpha |
Reports Updated as of Nov 30, 2023 |
PubMed |
Metachromatic leukodystrophy |
• Arylsulfatase A deficiency • MLD |
Metabolic disorders/Lysosomal storage disorders |
ARSA arylsulfatase A PSAP prosaposin ARSB arylsulfatase B |
Reports Updated as of Nov 30, 2023 |
PubMed |
Plasminogen deficiency |
• Hypoplasminogenemia |
Blood disorders |
PLG plasminogen |
Reports Updated as of Nov 30, 2023 |
PubMed |
Congenital afibrinogenemia |
• Congenital fibrinogen deficiency |
Blood disorders |
FGG fibrinogen gamma chain FGB fibrinogen beta chain FGA fibrinogen alpha chain |
Reports Updated as of Nov 30, 2023 |
PubMed |
Sandhoff disease |
• Hexosaminidases A and B deficiency |
Metabolic disorders/Lysosomal storage disorders |
HEXB hexosaminidase subunit beta |
Reports Updated as of Nov 30, 2023 |
PubMed |
Alpha-2-plasmin inhibitor deficiency |
• Congenital alpha2-antiplasmin deficiency • Alpha-2 Antiplasmin deficiency |
Blood disorders |
SERPINF2 serpin family F member 2 |
Reports Updated as of Nov 30, 2023 |
PubMed |
Vitamin K-dependent clotting factors, combined deficiency of, type 1 |
• Vitamin K-dependent coagulation defect • Congenital deficiency of vitamin K dependent clotting factors |
Blood disorders |
GGCX gamma-glutamyl carboxylase |
Reports Updated as of Nov 30, 2023 |
PubMed |
Alstrom syndrome |
• Alström Syndrome • Alstrom's syndrome |
Multisystemic disorders |
ALMS1 ALMS1 centrosome and basal body associated protein |
Reports Updated as of Nov 30, 2023 |
PubMed |
Behcet disease |
• Behçet disease • Behcet syndrome • Behcet's disease • Behcet's syndrome |
Skin disorders |
NOD2 nucleotide binding oligomerization domain containing 2 TNFRSF1A TNF receptor superfamily member 1A PSTPIP1 proline-serine-threonine phosphatase interacting protein 1 ADA2 adenosine deaminase 2 MEFV MEFV innate immunity regulator, pyrin |
Reports Updated as of Nov 30, 2023 |
PubMed |
Pili torti-deafness syndrome |
• Björnstad syndrome • Bjornstad syndrome |
Ear disorders/Hair disorders |
BCS1L BCS1 homolog, ubiquinol-cytochrome c reductase complex chaperone |
Reports Updated as of Nov 30, 2023 |
PubMed |
Bloom syndrome |
• BSyn • Bloom-Torre-Machacek syndrome |
Skin disorders |
BLM BLM RecQ like helicase |
Reports Updated as of Nov 30, 2023 |
PubMed |
CEDNIK syndrome |
• Cerebral dysgenesis-neuropathy-ichthyosis-palmoplantar keratoderma syndrome |
Skin disorders |
SNAP29 synaptosome associated protein 29 |
Reports Updated as of Nov 30, 2023 |
PubMed |
Cenani-Lenz syndactyly syndrome |
• Cenani-Lenz syndrome • Cenani syndactyly • Syndactyly type 7 |
Bone disorders |
LRP4 LDL receptor related protein 4 |
Reports Updated as of Nov 30, 2023 |
PubMed |
Classic homocystinuria |
• CBS deficiency • Cystathionine beta-synthase deficiency • Classical homocystinuria |
Metabolic disorders |
CBS cystathionine beta-synthase PKHD1 PKHD1 ciliary IPT domain containing fibrocystin/polyductin |
Reports Updated as of Nov 30, 2023 |
PubMed |
Congenital primary aphakia |
• Anterior segment dysgenesis 2 |
Eye disorders |
FOXE3 forkhead box E3 |
Reports Updated as of Nov 30, 2023 |
PubMed |
Filippi syndrome | Bone disorders |
CKAP2L cytoskeleton associated protein 2 like |
Reports Updated as of Dec 07, 2023 |
PubMed | |
LCAT deficiency |
• Norum disease • Familial lecithin cholesterol acyltransferase deficiency • Fish-eye disease • Familial LCAT deficiency |
Metabolic disorders |
LCAT lecithin-cholesterol acyltransferase |
Reports Updated as of Dec 07, 2023 |
PubMed |
Fraser syndrome |
• Cryptophthalmos syndrome • Fraser-cryptophthalmos syndrome |
Eye disorders |
FREM2 FRAS1 related extracellular matrix 2 FRAS1 Fraser extracellular matrix complex subunit 1 GRIP1 glutamate receptor interacting protein 1 |
Reports Updated as of Dec 07, 2023 |
PubMed |
Fucosidosis | Metabolic disorders/Lysosomal storage disorders |
FUCA1 alpha-L-fucosidase 1 DCX doublecortin |
Reports Updated as of Dec 07, 2023 |
PubMed | |
GAPO syndrome |
• Growth delay-alopecia-pseudoanodontia-optic atrophy syndrome |
Developmental / Multisystemic disorders |
ANTXR1 ANTXR cell adhesion molecule 1 |
Reports Updated as of Dec 07, 2023 |
PubMed |
Ghosal hematodiaphyseal dysplasia |
• GHDD |
Bone disorders |
TBXAS1 thromboxane A synthase 1 |
Reports Updated as of Dec 07, 2023 |
PubMed |
Ellis-van Creveld syndrome |
• Mesodermic dysplasia • Chondroectodermal dysplasia • Ellis Van Creveld syndrome |
Bone disorders |
EVC2 EvC ciliary complex subunit 2 EVC EvC ciliary complex subunit 1 |
Reports Updated as of Dec 07, 2023 |
PubMed |
Epidermodysplasia verruciformis |
• Lewandowsky-Lutz syndrome |
Skin disorders |
TMC8 transmembrane channel like 8 TMC6 transmembrane channel like 6 CIB1 calcium and integrin binding 1 |
Reports Updated as of Dec 07, 2023 |
PubMed |
Ethylmalonic encephalopathy |
• EPEMA syndrome |
Metabolic disorders |
ETHE1 ETHE1 persulfide dioxygenase |
Reports Updated as of Dec 07, 2023 |
PubMed |
Glanzmann thrombasthenia |
• Thrombasthenia |
Blood disorders |
ITGA2B integrin subunit alpha 2b ITGB3 integrin subunit beta 3 |
Reports Updated as of Dec 07, 2023 |
PubMed |
Gray platelet syndrome |
• Alpha storage pool deficiency |
Blood disorders |
NBEAL2 neurobeachin like 2 |
Reports Updated as of Dec 07, 2023 |
PubMed |
Ornithine aminotransferase deficiency |
• Gyrate atrophy of choroid and retina • Hyperornithinemia • Girate atrophy |
Metabolic disorders |
OAT ornithine aminotransferase |
Reports Updated as of Dec 07, 2023 |
PubMed |
H syndrome |
• Histiocytosis-lymphadenopathy plus syndrome • Asrar Facharzt Haque syndrome • Faisalabad histiocytosis |
Skin disorders |
SLC29A3 solute carrier family 29 member 3 |
Reports Updated as of Dec 07, 2023 |
PubMed |
Haim-Munk syndrome |
• Keratosis palmoplantaris with periodontopathia and onychogryposis • Papillon-Lefèvre syndrome • Cochin Jewish disorder |
Skin disorders |
CTSC cathepsin C |
Reports Updated as of Dec 07, 2023 |
PubMed |
Autosomal recessive congenital ichthyosis 4B |
• Harlequin ichthyosis • Ichthyosis congenita • Harlequin type |
Skin disorders |
ABCA12 ATP binding cassette subfamily A member 12 |
Reports Updated as of Dec 07, 2023 |
PubMed |
Congenital defect of folate absorption |
• Hereditary folate malabsorption |
Metabolic disorders |
SLC46A1 solute carrier family 46 member 1 |
Reports Updated as of Dec 07, 2023 |
PubMed |
Hereditary fructosuria |
• Hereditary fructose intolerance • Hereditary fructosemia • Hereditary fructose-1-phosphate aldolase deficiency |
Metabolic disorders |
ALDOB aldolase, fructose-bisphosphate B |
Reports Updated as of Dec 07, 2023 |
PubMed |
Hereditary pulmonary alveolar proteinosis |
• Pulmonary surfactant metabolism dysfunction • Congenital PAP • Congenital pulmonary alveolar proteinosis |
Respiratory disorders |
SFTPB surfactant protein B SFTPC surfactant protein C ABCA3 ATP binding cassette subfamily A member 3 |
Reports Updated as of Dec 07, 2023 |
PubMed |
Congenital secretory diarrhea, chloride type |
• Congenital chloride diarrhea • Familial Chloride Diarrhea |
Gastrointestinal disorders |
SLC26A3 solute carrier family 26 member 3 |
Reports Updated as of Dec 07, 2023 |
PubMed |
Cutaneous porphyria |
• Congenital erythropoietic porphyria • Günther disease |
Skin disorders |
UROS uroporphyrinogen III synthase |
Reports Updated as of Dec 07, 2023 |
PubMed |
Congenital disorder of glycosylation |
• Carbohydrate-deficient glycoprotein syndrome • Carbohydrate deficient glycoprotein syndrome • CDG • Congenital disorders of glycosylation |
Metabolic disorders |
ALG2 ALG2 alpha-1,3/1,6-mannosyltransferase DPM1 dolichyl-phosphate mannosyltransferase subunit 1, catalytic DDOST dolichyl-diphosphooligosaccharide--protein glycosyltransferase non-catalytic subunit NUS1 NUS1 dehydrodolichyl diphosphate synthase subunit PGM1 phosphoglucomutase 1 ALG3 ALG3 alpha-1,3- mannosyltransferase TUSC3 tumor suppressor candidate 3 DPAGT1 dolichyl-phosphate N-acetylglucosaminephosphotransferase 1 ALG8 ALG8 alpha-1,3-glucosyltransferase ALG9 ALG9 alpha-1,2-mannosyltransferase COG6 component of oligomeric golgi complex 6 MGAT2 alpha-1,6-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase COG7 component of oligomeric golgi complex 7 COG8 component of oligomeric golgi complex 8 MPDU1 mannose-P-dolichol utilization defect 1 COG2 component of oligomeric golgi complex 2 DHDDS dehydrodolichyl diphosphate synthase subunit FUT8 fucosyltransferase 8 RPN2 ribophorin II FCSK fucose kinase MAGT1 magnesium transporter 1 SRD5A3 steroid 5 alpha-reductase 3 ALG1 ALG1 chitobiosyldiphosphodolichol beta-mannosyltransferase ATP6AP2 ATPase H+ transporting accessory protein 2 GALNT2 polypeptide N-acetylgalactosaminyltransferase 2 SSR3 signal sequence receptor subunit 3 SLC37A4 solute carrier family 37 member 4 ALG13 ALG13 UDP-N-acetylglucosaminyltransferase subunit EDEM3 ER degradation enhancing alpha-mannosidase like protein 3 STT3A STT3 oligosaccharyltransferase complex catalytic subunit A SLC35A2 solute carrier family 35 member A2 CAMLG calcium modulating ligand COG3 component of oligomeric golgi complex 3 CACNA1D calcium voltage-gated channel subunit alpha1 D |
Reports Updated as of Dec 29, 2023 |
PubMed |
Dicarboxylic aminoaciduria |
• Glutamate-aspartate transport defect |
Metabolic disorders |
SLC1A1 solute carrier family 1 member 1 |
Reports Updated as of Dec 29, 2023 |
PubMed |
Dubowitz syndrome |
• Dwarfism-eczema-peculiar facies syndrome • Dubowitz's syndrome |
Skin disorders |
NSUN2 NOP2/Sun RNA methyltransferase 2 |
Reports Updated as of Dec 29, 2023 |
PubMed |
EAST syndrome |
• SeSAME syndrome • Seizures, Sensorineural deafness, Ataxia, Mental retardation, and Electrolyte imbalance Syndrome |
Neurodevelopmental disorders |
KCNJ10 potassium inwardly rectifying channel subfamily J member 10 |
Reports Updated as of Dec 29, 2023 |
PubMed |
Amelogenesis imperfecta type 1G |
• Enamel renal syndrome • Enamel-renal syndrome • Enamel-Renal-Gingival syndeome • Generalized enamel hypoplasia and renal dysfunction |
Oral disorders |
FAM20A FAM20A golgi associated secretory pathway pseudokinase |
Reports Updated as of Dec 29, 2023 |
PubMed |
Tyrosinemia type 1 |
• FAH deficiency • Fumarylacetoacetate hydrolase deficiency |
Metabolic disorders |
FAH fumarylacetoacetate hydrolase |
Reports Updated as of Dec 29, 2023 |
PubMed |
Glucocorticoid deficiency with achalasia |
• Triple A syndrome (Allgrove syndrome) • Achalasia-Addisonianism-Alacrima Syndrome • AAA syndrome |
Endocrine disorders |
AAAS aladin WD repeat nucleoporin |
Reports Updated as of Dec 29, 2023 |
PubMed |
Trichothiodystrophy | Skin disorders |
MPLKIP M-phase specific PLK1 interacting protein GTF2H5 general transcription factor IIH subunit 5 ERCC3 ERCC excision repair 3, TFIIH core complex helicase subunit ERCC2 ERCC excision repair 2, TFIIH core complex helicase subunit RNF113A ring finger protein 113A GTF2E2 general transcription factor IIE subunit 2 TARS1 threonyl-tRNA synthetase 1 AARS1 alanyl-tRNA synthetase 1 |
Reports Updated as of Dec 29, 2023 |
PubMed | |
Congenital amegakaryocytic thrombocytopenia | Blood disorders |
MPL MPL proto-oncogene, thrombopoietin receptor |
Reports Updated as of Dec 29, 2023 |
PubMed | |
Tangier disease |
• Analphalipo-proteinemia • Cholesterol thesaurismosi • Alpha high density lipoprotein deficiency disease • Tangier's disease |
Metabolic disorders |
ABCA1 ATP binding cassette subfamily A member 1 APOA1 apolipoprotein A1 |
Reports Updated as of Dec 29, 2023 |
PubMed |
Succinyl-CoA acetoacetate transferase deficiency |
• SCOT Deficiency • OXCT1 deficiency • Succinyl-CoA:3-oxoacid CoA transferase deficiency |
Metabolic disorders |
OXCT1 3-oxoacid CoA-transferase 1 |
Reports Updated as of Dec 29, 2023 |
PubMed |
Succinate-semialdehyde dehydrogenase deficiency |
• 4-hydroxybutyric aciduria • Gamma-hydroxybutyricaciduria • Succinic semialdehyde dehydrogenase deficiency |
Metabolic disorders |
ALDH5A1 aldehyde dehydrogenase 5 family member A1 |
Reports Updated as of Dec 29, 2023 |
PubMed |
Spondylocarpotarsal synostosis syndrome |
• Synspondylism • Spondylocarpotarsal synostosis |
Bone disorders |
FLNB filamin B MYH3 myosin heavy chain 3 |
Reports Updated as of Dec 29, 2023 |
PubMed |
Sneddon syndrome |
• Cerebro-vascular lesions and livedo reticularis • Idiopathic livedo reticularis with systemic involvement |
Skin disorders |
ADA2 adenosine deaminase 2 |
Reports Updated as of Dec 29, 2023 |
PubMed |
Smith-Lemli-Opitz syndrome |
• 7-Dehydrocholesterol reductase deficiency • Lethal Acrodysgenital syndrome • RSH syndrome |
Metabolic disorders |
DHCR7 7-dehydrocholesterol reductase |
Reports Updated as of Dec 29, 2023 |
PubMed |
Smith-McCort dysplasia |
• Smith-McCort dwarfism |
Bone disorders |
DYM dymeclin RAB33B RAB33B, member RAS oncogene family |
Reports Updated as of Dec 29, 2023 |
PubMed |
Sitosterolemia |
• Phytosterolemia |
Metabolic disorders |
ABCG8 ATP binding cassette subfamily G member 8 ABCG5 ATP binding cassette subfamily G member 5 |
Reports Updated as of Dec 29, 2023 |
PubMed |
Salla disease |
• Free sialic acid storage disease • Infantile sialic acid storage disorder (ISSD) |
Metabolic disorders |
SLC17A5 solute carrier family 17 member 5 |
Reports Updated as of Dec 29, 2023 |
PubMed |
Severe congenital nemaline myopathy | Neuromuscular disorders |
KLHL40 kelch like family member 40 |
Reports Updated as of Dec 29, 2023 |
PubMed | |
Sensory ataxic neuropathy, dysarthria, and ophthalmoparesis |
• Sensory ataxic neuropathy-dysarthria-ophthalmoparesis syndrome • Sensory ataxic neuropathy with dysarthria and ophthalmoplegia (SANDO) |
Neuromuscular disorders |
POLG DNA polymerase gamma, catalytic subunit TWNK twinkle mtDNA helicase |
Reports Updated as of Dec 29, 2023 |
PubMed |
Senior-Loken syndrome |
• Nephronophthisis with retinal dystrophy • Renal-retinal syndrome |
Eye disorders |
SDCCAG8 SHH signaling and ciliogenesis regulator SDCCAG8 CEP290 centrosomal protein 290 IQCB1 IQ motif containing B1 NPHP4 nephrocystin 4 WDR19 WD repeat domain 19 TRAF3IP1 TRAF3 interacting protein 1 NPHP1 nephrocystin 1 |
Reports Updated as of Dec 29, 2023 |
PubMed |
Sclerosteosis |
• Cortical hyperostosis-syndactyly syndrome |
Bone disorders |
SOST sclerostin LRP4 LDL receptor related protein 4 |
Reports Updated as of Jan 04, 2024 |
PubMed |
Schimke immuno-osseous dysplasia |
• Schimke immunoosseous dysplasia • Schimke syndrome • Spondyloepiphyseal dysplasia nephrotic syndrome |
Bone disorders |
SMARCAL1 SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a like 1 |
Reports Updated as of Jan 04, 2024 |
PubMed |
Ramon syndrome |
• Gingival fibromatosis combined with cherubism • Cherubism-gingival fibromatosis-intellectual disability syndrome |
Oral disorders |
ELMO2 engulfment and cell motility 2 |
Reports Updated as of Jan 04, 2024 |
PubMed |
Pyridoxine-dependent epilepsy |
• Vitamin B6-dependent seizures • Antiquitin deficiency • Pyridoxine dependency |
Metabolic disorders |
ALDH7A1 aldehyde dehydrogenase 7 family member A1 |
Reports Updated as of Jan 04, 2024 |
PubMed |
Pyridoxal phosphate-responsive seizures |
• PNPO deficiency • Pyridoxal 5-phosphate-dependent epilepsy • Pyridoxamine 5-prime-phosphate oxidase deficiency |
Metabolic disorders |
PNPO pyridoxamine 5'-phosphate oxidase |
Reports Updated as of Jan 04, 2024 |
PubMed |
Pyle metaphyseal dysplasia |
• Pyle disease • Metaphyseal dysostosis • Pyle's disease |
Bone disorders |
SFRP4 secreted frizzled related protein 4 |
Reports Updated as of Jan 04, 2024 |
PubMed |
Pyknodysostosis |
• Pycnodysostosis |
Bone disorders |
CTSK cathepsin K |
Reports Updated as of Jan 04, 2024 |
PubMed |
Purine-nucleoside phosphorylase deficiency |
• PNP deficiency • PNPase deficiency • Purine nucleoside phosphorylase deficiency |
Metabolic disorders |
PNP purine nucleoside phosphorylase |
Reports Updated as of Jan 04, 2024 |
PubMed |
Pulmonary venoocclusive disease |
• Pulmonary veno-occlusive disease |
Respiratory disorders |
BMPR2 bone morphogenetic protein receptor type 2 EIF2AK4 eukaryotic translation initiation factor 2 alpha kinase 4 |
Reports Updated as of Jan 04, 2024 |
PubMed |
Pulmonary alveolar microlithiasis | Respiratory disorders |
SLC34A2 solute carrier family 34 member 2 |
Reports Updated as of Jan 04, 2024 |
PubMed | |
Pseudoxanthoma elasticum |
• Gronblad Strandberg syndrome • Autosomal recessive inherited pseudoxanthoma elasticum |
Skin disorders |
ABCC6 ATP binding cassette subfamily C member 6 |
Reports Updated as of Jan 04, 2024 |
PubMed |
Proximal myopathy with extrapyramidal signs |
• Myopathy with extrapyramidal signs |
Neuromuscular disorders |
MICU1 mitochondrial calcium uptake 1 |
Reports Updated as of Jan 04, 2024 |
PubMed |
Prune belly syndrome |
• Abdominal muscle deficiency syndrome • Eagle-Barret syndrome • Prune belly |
Nephrological disorders |
CHRM3 cholinergic receptor muscarinic 3 MYOCD myocardin FLNA filamin A |
Reports Updated as of Jan 04, 2024 |
PubMed |
Propionic acidemia |
• Hyperglycinemia with ketoacidosis and leukopenia • Ketotic hyperglycinemia • Propionic aciduria • Propionyl-CoA carboxylase deficiency |
Metabolic disorders |
PCCB propionyl-CoA carboxylase subunit beta PCCA propionyl-CoA carboxylase subunit alpha |
Reports Updated as of Jan 04, 2024 |
PubMed |
Methylmalonic acidemia |
• Methylmalonic aciduria • Isolated methylmalonic acidemia |
Metabolic disorders |
MCEE methylmalonyl-CoA epimerase ABCD4 ATP binding cassette subfamily D member 4 HCFC1 host cell factor C1 MMUT methylmalonyl-CoA mutase CD320 CD320 molecule MMAB metabolism of cobalamin associated B THAP11 THAP domain containing 11 MMAA metabolism of cobalamin associated A ACSF3 acyl-CoA synthetase family member 3 |
Reports Updated as of Jan 04, 2024 |
PubMed |
Prolidase deficiency |
• Hyperimidodipeptiduria |
Metabolic disorders |
PEPD peptidase D |
Reports Updated as of Jan 04, 2024 |
PubMed |
Miller syndrome |
• Postaxial acrofacial dysostosis • Acrofacial dysostosis,POADS • Postaxial acrodysostosis |
Bone disorders |
DHODH dihydroorotate dehydrogenase (quinone) |
Reports Updated as of Jan 04, 2024 |
PubMed |
Poikiloderma with neutropenia |
• Poikiloderma with neutropenia Clericuzio type |
Skin disorders |
USB1 U6 snRNA biogenesis phosphodiesterase 1 |
Reports Updated as of Jan 04, 2024 |
PubMed |
Pierson syndrome |
• Microcoria-congenital nephrosis syndrome |
Nephrological disorders |
LAMB2 laminin subunit beta 2 |
Reports Updated as of Jan 04, 2024 |
PubMed |
Perrault syndrome 1 |
• XX gonodal dysgenesis-deafness syndrome • Ovarian dysgenesis with sensorineural deafness • XX gonodal dysgenesis-hearing loss syndrome |
Endocrine disorders |
HSD17B4 hydroxysteroid 17-beta dehydrogenase 4 PRORP protein only RNase P catalytic subunit FBN1 fibrillin 1 CLPP caseinolytic mitochondrial matrix peptidase proteolytic subunit |
Reports Updated as of Jan 04, 2024 |
PubMed |
Otospondylomegaepiphyseal dysplasia |
• Spondylo-megaepiphyseal-metaphyseal dysplasia • OSMED Syndrome |
Bone disorders |
COL11A2 collagen type XI alpha 2 chain COL2A1 collagen type II alpha 1 chain |
Reports Updated as of Jan 04, 2024 |
PubMed |
Opsismodysplasia | Bone disorders |
INPPL1 inositol polyphosphate phosphatase like 1 |
Reports Updated as of Jan 04, 2024 |
PubMed | |
Obesity due to congenital leptin deficiency |
• Leptin deficiency or dysfunction • Leptin deficiency |
Endocrine disorders |
LEP leptin |
Reports Updated as of Jan 04, 2024 |
PubMed |
Neutral lipid storage myopathy |
• Neutral lipid storage disease without ichthyosis |
Metabolic disorders/Lysosomal storage disorders |
PNPLA2 patatin like phospholipase domain containing 2 |
Reports Updated as of Jan 04, 2024 |
PubMed |
Acroerythrokeratoderma |
• Mal de Meleda • Meleda Disease • Keratosis palmoplantaris transgradiens of Siemens |
Skin disorders |
SLURP1 secreted LY6/PLAUR domain containing 1 |
Reports Updated as of Jan 04, 2024 |
PubMed |
Bamforth-Lazarus syndrome |
• Athyroidal Hypothyroidism with Spiky Hair and Cleft Palate |
Endocrine disorders |
FOXE1 forkhead box E1 |
Reports Updated as of Feb 01, 2024 |
PubMed |
Naxos disease |
• Keratosis palmoplantaris with arrythmogenic cardiomyopathy • Mal de Naxos • Arrhythmogenic Right Ventricular Dysplasia |
Cardiovascular disorders |
JUP junction plakoglobin |
Reports Updated as of Feb 01, 2024 |
PubMed |
Citrullinemia type I |
• Argininosuccinate synthetase deficiency • Citrullinemia 1 • Classic citrullinemia • ASS deficiency |
Metabolic disorders |
SLC25A13 solute carrier family 25 member 13 ASS1 argininosuccinate synthase 1 |
Reports Updated as of Feb 01, 2024 |
PubMed |
Multiple gastrointestinal atresias |
• Multiple intestinal atresia • Familial intestinal polyatresia syndrome |
Gastrointestinal disorders |
TTC7A tetratricopeptide repeat domain 7A |
Reports Updated as of Feb 01, 2024 |
PubMed |
Multiple sulfatase deficiency |
• Juvenile sulfatidosis, Austin type • Mucosulfatidosis • Multiple sulfatase deficiency disease • Juvenile sulfatidosis |
Metabolic disorders/Lysosomal storage disorders |
SUMF1 sulfatase modifying factor 1 SUMF2 sulfatase modifying factor 2 |
Reports Updated as of Feb 01, 2024 |
PubMed |
Muscle eye brain disease |
• Santavuori congenital muscular dystrophy • Muscle-eye-brain disease |
Neuromuscular disorders |
POMGNT1 protein O-linked mannose N-acetylglucosaminyltransferase 1 (beta 1,2-) |
Reports Updated as of Feb 01, 2024 |
PubMed |
Ehlers-Danlos syndrome, musculocontractural type |
• Musculocontractural Ehlers-Danlos syndrome • Adducted thumb-clubfoot syndrome • Dündar syndrome |
Bone disorders |
CHST14 carbohydrate sulfotransferase 14 DSE dermatan sulfate epimerase |
Reports Updated as of Feb 01, 2024 |
PubMed |
Polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy |
• Nasu-Hakola disease • PLOSL |
Bone disorders |
TREM2 triggering receptor expressed on myeloid cells 2 TYROBP transmembrane immune signaling adaptor TYROBP |
Reports Updated as of Feb 01, 2024 |
PubMed |
Mulibrey nanism syndrome |
• Muscle-liver-brain-eye nanism • Perheentupa syndrome • Mulibrey Nanism • Pericardial constriction and growth failure |
Bone disorders |
TRIM37 tripartite motif containing 37 |
Reports Updated as of Feb 01, 2024 |
PubMed |
Multicentric osteolysis nodulosis arthropathy |
• Nodulosis arthropathy osteolysis syndrome • NAO syndrome • NOA syndrome • Torg syndrome • Torg-Winchester syndrome |
Bone disorders |
MMP2 matrix metallopeptidase 2 LPCAT2 lysophosphatidylcholine acyltransferase 2 |
Reports Updated as of Feb 01, 2024 |
PubMed |
Mosaic variegated aneuploidy syndrome 2 |
• Mosaic variegated aneuploidy syndrome |
Multisystemic disorders |
CEP57 centrosomal protein 57 |
Reports Updated as of Feb 01, 2024 |
PubMed |
Majeed syndrome |
• Congenital dyserythropoietic anemia and chronic recurrent multifocal osteomyelitis • Dyserythropoietic anemia, and neutrophilic dermatosis • CDA and CRMO |
Bone disorders |
LPIN2 lipin 2 |
Reports Updated as of Feb 01, 2024 |
PubMed |
Mesoaxial synostotic syndactyly with phalangeal reduction |
• Syndactyly type 9 • Syndactyly Malik-Percin type |
Bone disorders |
BHLHA9 basic helix-loop-helix family member a9 |
Reports Updated as of Feb 01, 2024 |
PubMed |
Mevalonic aciduria |
• Complete mevalonate kinase deficiency • Mevalonate kinase deficiency • Mevalonicaciduria |
Metabolic disorders |
MVK mevalonate kinase |
Reports Updated as of Feb 01, 2024 |
PubMed |
Miyoshi muscular dystrophy |
• Miyoshi myopathy • Dysferlinopathy • Miyoshi distal myopathy |
Neuromuscular disorders |
ANO5 anoctamin 5 DYSF dysferlin |
Reports Updated as of Feb 01, 2024 |
PubMed |
Lysinuric protein intolerance |
• Dibasicamino aciduria II • Hyperdibasic aminoaciduria • LPI |
Metabolic disorders |
SLC7A7 solute carrier family 7 member 7 |
Reports Updated as of Feb 01, 2024 |
PubMed |
Macular corneal dystrophy |
• Groenouw type II corneal dystrophy • Fehr corneal dystrophy • MCD • Macular dystrophy, corneal type 1 |
Eye disorders |
CHST6 carbohydrate sulfotransferase 6 |
Reports Updated as of Feb 01, 2024 |
PubMed |
Lipid proteinosis |
• Lipoid Proteinosis • LipoproteinosisHyalinosis cutis et mucosae • Urbach-Wiethe disease |
Metabolic disorders |
ECM1 extracellular matrix protein 1 |
Reports Updated as of Feb 01, 2024 |
PubMed |
Lathosterolosis |
• Sterol C5-desaturase deficiency • SC5D deficiency |
Metabolic disorders |
SC5D sterol-C5-desaturase |
Reports Updated as of Feb 01, 2024 |
PubMed |
Langer mesomelic dysplasia syndrome |
• Dyschondrosteosis, homozygous • Langer Mesomelic Dwarfism • Langer mesomelic dysplasia • Mesomelic dwarfism of the hypoplastic ulna, fibula and mandible type |
Bone disorders |
SHOX SHOX homeobox |
Reports Updated as of Feb 01, 2024 |
PubMed |
Lafora disease |
• Myoclonic epilepsy of Lafora • EPM2A-Related Lafora Disease • Epilepsy progressive myoclonic 2 • Lafora body disorder • Progressive Myoclonus Epilepsy, Lafora Typ • EPM2 • PME type 2 |
Neurodegenerative disorders |
EPM2A EPM2A glucan phosphatase, laforin NHLRC1 NHL repeat containing E3 ubiquitin protein ligase 1 |
Reports Updated as of Feb 01, 2024 |
PubMed |
Knobloch syndrome |
• Myopia retinal detachment encephalocele • Retinal detachment-occipital encephalocele syndrome • Knobloch-Layer syndrome |
Eye disorders |
COL18A1 collagen type XVIII alpha 1 chain PAK2 p21 (RAC1) activated kinase 2 |
Reports Updated as of Feb 01, 2024 |
PubMed |
Hereditary acrodermatitis enteropathica |
• Acrodermatitis enteropathica • Inherited zinc deficiency • Acrodermatitis enteropathica zinc deficiency type • Brandt syndrome • Danbolt-Cross syndrome |
Metabolic disorders |
SLC39A4 solute carrier family 39 member 4 |
Reports Updated as of Feb 01, 2024 |
PubMed |
Acatalasia |
• Acatalasemia • Catalase deficiency |
Metabolic disorders |
CAT catalase |
Reports Updated as of Feb 01, 2024 |
PubMed |
Abetalipoproteinaemia |
• Abetalipoproteinemia • Abetalipoproteinemia neuropathy • Bassen Kornzweig syndrome • Betalipoprotein deficiency disease • Congenital betalipoprotein deficiency syndrome • Low-density beta lipoprotein deficiency • Microsomal-triglyceride transfer protein deficiency |
Metabolic disorders |
MTTP microsomal triglyceride transfer protein |
Reports Updated as of Feb 01, 2024 |
PubMed |
Adenylosuccinate lyase deficiency |
• ADSL deficiency • Adenylosuccinase deficiency |
Metabolic disorders |
ADSL adenylosuccinate lyase |
Reports Updated as of Feb 01, 2024 |
PubMed |
Adenine phosphoribosyltransferase deficiency |
• APRT deficiency • Dihydroxyadeninuria • 2,8-dihydroxyadenine urolithiasis |
Metabolic disorders |
APRT adenine phosphoribosyltransferase |
Reports Updated as of Feb 01, 2024 |
PubMed |
Adult polyglucosan body disease |
• Polyglucosan body disease, adult form |
Metabolic disorders |
GBE1 1,4-alpha-glucan branching enzyme 1 |
Reports Updated as of Feb 01, 2024 |
PubMed |
Amelocerebrohypohidrotic syndrome |
• Kohlschütter-Tönz syndrome • Epilepsy-dementia-amelogenesis imperfecta syndrome • Epilepsy and yellow teeth |
Neurodegenerative disorders |
ROGDI rogdi atypical leucine zipper |
Reports Updated as of Feb 01, 2024 |
PubMed |
Apparent mineralocorticoid excess |
• 11-beta-hydroxysteroid dehydrogenase deficiency type 2 • Apparent Mineralocorticoid Excess Syndrome • Cortisol 11-beta-ketoreductase deficiency • Ulick syndrome |
Endocrine disorders |
HSD11B2 hydroxysteroid 11-beta dehydrogenase 2 |
Reports Updated as of Feb 01, 2024 |
PubMed |
Aromatase deficiency |
• Pseudohermaphroditism, female, due to placental aromatase deficiency • Increased aromatase activity • Congenital estrogen deficiency |
Endocrine disorders |
CYP19A1 cytochrome P450 family 19 subfamily A member 1 |
Reports Updated as of Feb 01, 2024 |
PubMed |
Leprechaunism syndrome |
• Donohue syndrome • Leprechaunism |
Endocrine disorders |
INSR insulin receptor |
Reports Updated as of Feb 01, 2024 |
PubMed |
Karyomegalic interstitial nephritis |
• Systemic karyomegaly • KIN |
Nephrological disorders |
FAN1 FANCD2 and FANCI associated nuclease 1 |
Reports Updated as of Feb 01, 2024 |
PubMed |
Orthostatic hypotension 1 |
• Dopamine beta-hydroxylase deficiency • Noradrenaline deficiency • Norepinephrine deficiency • DBH deficiency • Orthostatic hypotension 1, due to DBH deficiency |
Metabolic disorders |
DBH dopamine beta-hydroxylase |
Reports Updated as of Feb 20, 2024 |
PubMed |
Pyruvate carboxylase deficiency |
• Ataxia with lactic acidosis 2 • Leigh necrotizing encephalopathy due to pyruvate carboxylase deficiency • PC deficiency |
Metabolic disorders |
PC pyruvate carboxylase |
Reports Updated as of Feb 20, 2024 |
PubMed |
Hyperprolinemia type 2 |
• Delta-1-pyrroline-5-carboxylate dehydrogenase deficiency • Deficiency of pyrroline-5-carboxylate reductase • Hyperprolinemia, Type II |
Metabolic disorders |
ALDH4A1 aldehyde dehydrogenase 4 family member A1 |
Reports Updated as of Feb 20, 2024 |
PubMed |
3-hydroxy-3-methylglutaryl-CoA synthase deficiency |
• HMG-CoA synthase deficiency • HMGCS2 deficiency • 3-hydroxy-3-methylglutaryl-CoA synthase 2 deficiency • HMG-CoA synthase-2 deficiency • Mitochondrial HMG-CoA synthase deficiency |
Metabolic disorders |
HMGCS2 3-hydroxy-3-methylglutaryl-CoA synthase 2 |
Reports Updated as of Feb 20, 2024 |
PubMed |
Deficiency of acetyl-CoA acetyltransferase |
• Beta-ketothiolase deficiency • 2-methyl-3-hydroxybutyricacidemia • 3-ketothiolase deficiency • 3-oxothiolase deficiency • Alpha-methylacetoaceticaciduria • Beta ketothiolase deficiency • Ketothiolase deficiency • Mitochondrial acetoacetyl-CoA Thiolase deficiency |
Metabolic disorders |
ACAT1 acetyl-CoA acetyltransferase 1 |
Reports Updated as of Feb 20, 2024 |
PubMed |
Deficiency of guanidinoacetate methyltransferase |
• Cerebral creatine deficiency syndrome 2 • Guanidinoacetate methyltransferase deficiency • GAMT deficiency |
Metabolic disorders |
GAMT guanidinoacetate N-methyltransferase |
Reports Updated as of Feb 20, 2024 |
PubMed |
Primary hyperoxaluria, type I |
• Glycolic aciduria • Hepatic AGT deficiency • Primary hyperoxaluria type 1 • Oxalosis 1 • Peroxisomal alanine glyoxylate aminotransferase deficiency • Serine pyruvate aminotransferase deficiency |
Metabolic disorders |
GRHPR glyoxylate and hydroxypyruvate reductase AGXT alanine--glyoxylate aminotransferase |
Reports Updated as of Feb 20, 2024 |
PubMed |
Primary hyperoxaluria, type II |
• D-glycerate dehydrogenase deficiency • L-glyceric aciduria • Glyceric aciduria • Oxalosis 2 • Primary hyperoxaluria type 2 • Glyoxylate reductase/hydroxypyruvate reductase deficiency |
Metabolic disorders |
GRHPR glyoxylate and hydroxypyruvate reductase |
Reports Updated as of Feb 20, 2024 |
PubMed |
Sulfite oxidase deficiency |
• Sulfocysteinuria • ISOD • Isolated sulfite oxidase deficiency |
Metabolic disorders |
SUOX sulfite oxidase GPHN gephyrin MOCS2 molybdenum cofactor synthesis 2 MOCS1 molybdenum cofactor synthesis 1 |
Reports Updated as of Feb 20, 2024 |
PubMed |
Non-ketotic hyperglycinemia |
• Glycine encephalopathy • Nonketotic hyperglycinemia • AMT-Related Glycine Encephalopathy • GLDC-Related Glycine Encephalopathy |
Metabolic disorders |
AMT aminomethyltransferase GLDC glycine decarboxylase GCSH glycine cleavage system protein H PCDH19 protocadherin 19 |
Reports Updated as of Feb 20, 2024 |
PubMed |
Dihydropyrimidinase deficiency |
• Dihydropyrimidinuria • DPH deficiency • DPYS deficiency |
Metabolic disorders |
DPYS dihydropyrimidinase |
Reports Updated as of Feb 20, 2024 |
PubMed |
Deficiency of butyrylcholinesterase |
• Pseudocholinesterase deficiency • Butyrylcholinesterase deficiency • Acholinesterasemia • Acylcholine acylhydrolase deficiency • BCHE deficiency • CHE1 deficiency |
Metabolic disorders |
BCHE butyrylcholinesterase |
Reports Updated as of Feb 20, 2024 |
PubMed |
Fumarase deficiency |
• Fumaric aciduria • Fumarate hydratase deficiency |
Metabolic disorders |
FH fumarate hydratase |
Reports Updated as of Feb 20, 2024 |
PubMed |
Brown-Vialetto-van Laere syndrome 1 |
• Riboflavin transporter deficiency • Brown-Vialetto-van Laere syndrome • Pontobulbar palsy and neurosensory deafness |
Neurodegenerative disorders |
SLC52A3 solute carrier family 52 member 3 |
Reports Updated as of Feb 20, 2024 |
PubMed |
Schwartz-Jampel syndrome |
• Myotonic myopathy dwarfism chondrodystrophy and ocular and facial abnormalities • Schwartz Jampel syndrome type 1 • Aberfeld syndrome • Burton skeletal dysplasia • Burton syndrome • Catel-Hempel syndrome • Dysostosis enchondralis metaepiphysaria, Catel-Hempel type • Myotonic chondrodystrophy • Myotonic myopathy, dwarfism, chondrodystrophy |
Bone disorders |
HSPG2 heparan sulfate proteoglycan 2 |
Reports Updated as of Feb 20, 2024 |
PubMed |
Phytanic acid storage disease |
• Refsum disease • Heredopathia atactica polyneuritiformis • Hypertrophic neuropathy of Refsum • PEX7-Related Refsum disease • PHYH-Related Refsum disease • Phytanic acid oxidase deficiency • Adult Refsum disease • HMSN 4 • Hereditary motor and sensory neuropathy type 4 • Heredopathia atactica polyneuritiformis • Phytanic-CoA hydroxylase deficiency |
Metabolic disorders |
PHYH phytanoyl-CoA 2-hydroxylase PEX7 peroxisomal biogenesis factor 7 |
Reports Updated as of Feb 20, 2024 |
PubMed |
Autoimmune hemolytic anemia |
• AHA • AIHA |
Blood disorders |
SOCS1 suppressor of cytokine signaling 1 TLR8 toll like receptor 8 |
Reports Updated as of Feb 20, 2024 |
PubMed |
Arterial tortuosity syndrome |
• ATS |
Cardiovascular disorders |
SLC2A10 solute carrier family 2 member 10 |
Reports Updated as of Feb 20, 2024 |
PubMed |
Congenital diaphragmatic hernia |
• CDH |
Respiratory disorders |
PAX3 paired box 3 FREM1 FRAS1 related extracellular matrix 1 FBN1 fibrillin 1 FREM2 FRAS1 related extracellular matrix 2 LZTR1 leucine zipper like post translational regulator 1 PLS3 plastin 3 |
Reports Updated as of Feb 20, 2024 |
PubMed |
Carpenter syndrome |
• Acrocephalopolysyndactyly type 2 • ACPS2 • RAB23-related Carpenter syndrome • Acrocephalopolysyndactyly Type II • Carpenter syndrome 1 |
Bone disorders |
RAB23 RAB23, member RAS oncogene family MEGF8 multiple EGF like domains 8 |
Reports Updated as of Feb 20, 2024 |
PubMed |
Spinocerebellar ataxia type 3 |
• Azorean disease • Azorean neurologic disease • Machado-Joseph disease • Nigrospinodentatal degeneration • Spinocerebellar atrophy type 3 |
Neurodegenerative disorders |
ATXN3 ataxin 3 |
Reports Updated as of Apr 17, 2024 |
PubMed |
Spinocerebellar ataxia type 16 |
• Spinocerebellar ataxia type 15/16 • Spinocerebellar Ataxia Type 15 • SCA16 (formerly) |
Neurodegenerative disorders |
ITPR1 inositol 1,4,5-trisphosphate receptor type 1 |
Reports Updated as of Apr 17, 2024 |
PubMed |
Tyrosinemia type II |
• TAT deficiency • Keratosis palmoplantaris with corneal dystrophy • Oculocutaneous tyrosinemia • Oregon type tyrosinemia • Richner Hanhart syndrome • Tyrosine aminotransferase deficiency • Tyrosine transaminase deficiency • Tyrosinemia type 2 • Tyrosinosis oculocutaneous type |
Metabolic disorders |
TAT tyrosine aminotransferase HPD 4-hydroxyphenylpyruvate dioxygenase |
Reports Updated as of Jul 20, 2024 |
PubMed |
Glycogen storage disease due to glucose-6-phosphatase deficiency type IA |
• Glucose-6-phosphatase deficiency • Glucose-6-phosphatase deficiency glycogen storage disease • Glycogen Storage Disease Type Ia • Glycogen storage disease type 1A • Glycogenosis type 1 • Hepatorenal form of glycogen storage disease • Hepatorenal glycogenosis • Von Gierke disease • Glycogen storage disease due to glucose-6-phosphatase deficiency type Ia • G6P deficiency type 1a • GSD due to G6P deficiency type Ia • GSDIa |
Metabolic disorders |
G6PC1 glucose-6-phosphatase catalytic subunit 1 |
Reports Updated as of Jul 20, 2024 |
PubMed |
Glycogen storage disease type III |
• Glycogen storage disease due to glycogen debranching enzyme deficiency • Amylo-1,6-glucosidase deficiency • Cori disease • Cori-Forbes disease • Forbes disease • Limit dextrinosis • GDE deficiency • GSD due to glycogen debranching enzyme deficiency • GSD type 3 • GSDIII • Glycogen storage disease type 3 • Glycogen storage disease type III |
Metabolic disorders |
AGL amylo-alpha-1, 6-glucosidase, 4-alpha-glucanotransferase AFG3L2 AFG3 like matrix AAA peptidase subunit 2 |
Reports Updated as of Jul 20, 2024 |
PubMed |
Glycogen storage disease, type IV |
• GBE1 deficiency • Amylopectinosis • Andersen disease • Brancher deficiency • Cirrhosis, familial, with deposition of abnormal glycogen • Glycogenosis IV • GSD IV • Glycogen branching enzyme deficiency • Glycogen storage disease due to glycogen branching enzyme deficiency • Glycogen storage disease type 4 |
Metabolic disorders |
GBE1 1,4-alpha-glucan branching enzyme 1 RBCK1 RANBP2-type and C3HC4-type zinc finger containing 1 |
Reports Updated as of Jul 20, 2024 |
PubMed |
Glutaric aciduria, type 1 |
• Glutaryl-CoA dehydrogenase deficiency • Glutaric acidemia type 1 • Glutaric acidemia type I • Glutaricacidemia Type 1 • Glutaricaciduria, type I |
Metabolic disorders |
GCDH glutaryl-CoA dehydrogenase |
Reports Updated as of Jul 20, 2024 |
PubMed |
Congenital glucose-galactose malabsorption |
• Glucose-galactose malabsorption • SGLT1 deficiency • Complex carbohydrate intolerance • Carbohydrate intolerance of glucose galactose • Glucose galactose malabsorption deficiency • Glucose-Galactose Malabsorption • Monosaccharide malabsorption |
Metabolic disorders |
SLC5A1 solute carrier family 5 member 1 |
Reports Updated as of Jul 20, 2024 |
PubMed |
Autosomal recessive osteopetrosis 8 |
• OSTEOPETROSIS, AUTOSOMAL RECESSIVE 8 • OPTB8 |
Bone disorders |
SNX10 sorting nexin 10 |
Reports Updated as of Jul 20, 2024 |
PubMed |
Autosomal recessive osteopetrosis 1 |
• Osteopetrosis, autosomal recessive 1 • Albers-Schonberg disease, autosomal recessive • Marble bones autosomal recessive • Osteopetrosis infantile malignant 1 • TCIRG1-related autosomal recessive osteopetrosis |
Bone disorders |
TCIRG1 T cell immune regulator 1, ATPase H+ transporting V0 subunit a3 |
Reports Updated as of Jul 20, 2024 |
PubMed |
Osteopetrosis with renal tubular acidosis |
• Autosomal recessive osteopetrosis type 3 • Carbonic anhydrase 2 deficiency • Guibaud Vainsel syndrome • Marble brain disease • Osteopetrosis, autosomal recessive 3, with renal tubular acidosis |
Bone disorders |
CA2 carbonic anhydrase 2 |
Reports Updated as of Jul 20, 2024 |
PubMed |
MHC class II deficiency |
• Immunodeficiency by defective expression of MHC class II • Bare lymphocyte syndrome type 2 • Bare lymphocyte syndrome, type II, complementation group a • Bare Lymphocyte Syndrome • Bare lymphocyte syndrome 2 • SCID, HLA CLASS II-NEGATIVE • SCID, HLA Class 2-Negative • Severe combined immunodeficiency, HLA class II negative |
Immune disorders |
RFXANK regulatory factor X associated ankyrin containing protein RFX5 regulatory factor X5 RFXAP regulatory factor X associated protein CIITA class II major histocompatibility complex transactivator |
Reports Updated as of Jul 20, 2024 |
PubMed |
Multiple mitochondrial dysfunctions syndrome 5 |
• ISCA1 deficiency • MMDS5 |
Metabolic disorders |
ISCA1 iron-sulfur cluster assembly 1 |
Reports Updated as of Jul 20, 2024 |
PubMed |
Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1 |
• Combined oxidative phosphorylation deficiency 1 • Hepatoencephalopathy, early fatal progressive |
Metabolic disorders |
GFM1 G elongation factor mitochondrial 1 NARS2 asparaginyl-tRNA synthetase 2, mitochondrial MRPL44 mitochondrial ribosomal protein L44 |
Reports Updated as of Jul 20, 2024 |
PubMed |
Combined oxidative phosphorylation defect type 27 |
• Combined oxidative phosphorylation deficiency 27 |
Metabolic disorders |
CARS2 cysteinyl-tRNA synthetase 2, mitochondrial |
Reports Updated as of Jul 20, 2024 |
PubMed |
Combined oxidative phosphorylation deficiency 53 |
• Neurodevelopmental disorder with hypotonia, microcephaly, and seizures (NEDHYMS) • C2orf69-associated COXPD53 • Elbracht-Isikay syndrome • Global developmental delay, progressive microcephaly, structural brain abnormalities, and autoinflammation |
Neurodevelopmental disorders |
C2orf69 chromosome 2 open reading frame 69 |
Reports Updated as of Jul 20, 2024 |
PubMed |
Mitochondrial DNA depletion syndrome 6 (hepatocerebral type) |
• Navajo neuropathy • Mitochondrial DNA depletion syndrome type 6 • Navajo neurohepatopathy |
Metabolic disorders |
MPV17 mitochondrial inner membrane protein MPV17 |
Reports Updated as of Jul 20, 2024 |
PubMed |
Aicardi-Goutieres syndrome 6 |
• Aicardi-Goutières syndrome • Encephalopathy with basal ganglia calcification • Encephalopathy with intracranial calcification and chronic lymphocytosis of cerebrospinal fluid • Pseudo-Torch syndrome • Aicardi-Toutieres syndrome • Type 6Aicardi-Goutieres syndrome 1 |
Multisystemic disorders |
ADAR adenosine deaminase RNA specific |
Reports Updated as of Jul 20, 2024 |
PubMed |
Aicardi-Goutieres syndrome 4 |
• Aicardi-Goutières syndrome • Encephalopathy with basal ganglia calcification • Encephalopathy with intracranial calcification and chronic lymphocytosis of cerebrospinal fluid • Pseudo-Torch syndrome • Aicardi-Toutieres syndrome |
Multisystemic disorders |
RNASEH2A ribonuclease H2 subunit A |
Reports Updated as of Jul 20, 2024 |
PubMed |
Intestinal hypomagnesemia 1 |
• Primary hypomagnesemia with secondary hypocalcemia • Hypomagnesemia with secondary hypocalcemia • Hypomagnesemia tatany • Intestinal hypomagnesemia with secondary hypocalcemia • Hypomagnesemia caused by selective magnesium malabsorption • Hypomagnesemia intestinal type 1 • PHSH • HOMG1 • HSH |
Metabolic disorders |
TRPM6 transient receptor potential cation channel subfamily M member 6 TRPM7 transient receptor potential cation channel subfamily M member 7 |
Reports Updated as of Jul 20, 2024 |
PubMed |
Primary hypomagnesemia |
• Familial primary hypomagnesemia with hypercalciuria and nephrocalcinosis • Primary hypomagnesemia with hypercalciuria and nephrocalcinosis • FHHNC syndrome • Familial hypomagnesemia, hypercalciuria with nephrocalcinosis |
Metabolic disorders |
CLDN16 claudin 16 |
Reports Updated as of Jul 20, 2024 |
PubMed |
Kartagener syndrome |
• Dextrocardia bronchiectasis and sinusitis • Immotile cilia syndrome • Ciliary dyskinesia, primary, 1 • Ciliary dyskinesia, primary, 1, with or without situs inversus • Polynesian bronchiectasis • Primary ciliary dyskinesia 1: DNAI1-related primary ciliary dyskinesia • Siewert syndrome |
Respiratory disorders |
DNAI1 dynein axonemal intermediate chain 1 DNAH1 dynein axonemal heavy chain 1 DNAH5 dynein axonemal heavy chain 5 CCDC40 coiled-coil domain 40 molecular ruler complex subunit ODAD3 outer dynein arm docking complex subunit 3 DRC1 dynein regulatory complex subunit 1 |
Reports Updated as of Jul 20, 2024 |
PubMed |
Acrodermatitis continua suppurativa of Hallopeau |
• Acrodermatitis continua of hallopeau • Interleukin 36 receptor antagonist deficiency • Psoriasis 14, pustular |
Skin disorders |
IL36RN interleukin 36 receptor antagonist |
Reports Updated as of Jul 20, 2024 |
PubMed |
Ocular cystinosis |
• Non-Nephropathic cystinosis • Cystinosis, adult, nonnephropathic • Cystinosis, benign, nonnephropathic • Cystinosis, ocular nonnephropathic |
Metabolic disorders/Lysosomal storage disorders |
CTNS cystinosin, lysosomal cystine transporter |
Reports Updated as of Jul 20, 2024 |
PubMed |
Bartter disease type 2 |
• Hyperprostaglandin E syndrome 2 • Bartter syndrome, type 2, antenatal • Hypokalemic alkalosis with hypercalciuria 2, antenatal |
Nephrological disorders |
KCNJ1 potassium inwardly rectifying channel subfamily J member 1 |
Reports Updated as of Jul 20, 2024 |
PubMed |
Familial hypokalemia-hypomagnesemia |
• Gitelman Syndrome • Potassium and magnesium depletion • Hypomagnesemia-hypokalemia, primary renotubular, with hypocalciuria |
Nephrological disorders |
SLC12A3 solute carrier family 12 member 3 MMP2-AS1 MMP2 antisense RNA 1 |
Reports Updated as of Jul 20, 2024 |
PubMed |
Xanthinuria type II |
• XDH and AOX dual deficiency • Xanthine dehydrogenase and aldehyde oxidase combined deficiency of Xanthinuria type 2 • Xanthine dehydrogenase and xanthine aldehyde oxidase dual deficiency |
Metabolic disorders |
MOCOS molybdenum cofactor sulfurase XDH xanthine dehydrogenase |
Reports Updated as of Jul 20, 2024 |
PubMed |
Hyperornithinemia-hyperammonemia-homocitrullinuria syndrome |
• Ornithine translocase deficiency syndrome • HHH syndrome • ORNT1 deficiency • Ornithine carrier deficiency • Ornithine translocase deficiency • Triple H syndrome |
Metabolic disorders |
SLC25A15 solute carrier family 25 member 15 |
Reports Updated as of Jul 20, 2024 |
PubMed |
3-Oxo-5 alpha-steroid delta 4-dehydrogenase deficiency |
• Steroid 5-alpha-reductase 2 deficiency • 46,XY DSD due to 5-alpha-reductase 2 deficiency • Pseudovaginal perineoscrotal hypospadias • Familial incomplete male pseudohermaphroditism, type 2 • Male pseudohermaphroditism due to 5-alpha-reductase deficiency |
Reproductive disorders |
SRD5A2 steroid 5 alpha-reductase 2 |
Reports Updated as of Jul 20, 2024 |
PubMed |
Werner syndrome |
• adult premature aging syndrome • adult premature ageing syndrome • Werner's syndrome • adult progeria • WS |
Aging disorders |
WRN WRN RecQ like helicase |
Reports Updated as of Feb 01, 2025 |
PubMed |
Osteoporosis with pseudoglioma |
• Osteoporosis-pseudoglioma syndrome • ocular form of osteogenesis imperfecta • osteogenesis imperfecta ocular form • osteoporosis pseudoglioma syndrome • pseudoglioma with bone fragility |
Bone disorders |
LRP5 LDL receptor related protein 5 |
Reports Updated as of Feb 01, 2025 |
PubMed |
Wolcott-Rallison dysplasia |
• Multiple epiphyseal dysplasia with early-onset diabetes mellitus • Wolcott-rallison syndrome • MED-IDDM syndrome • Wolcott Rallison syndrome |
Multisystemic disorders |
EIF2AK3 eukaryotic translation initiation factor 2 alpha kinase 3 |
Reports Updated as of Feb 01, 2025 |
PubMed |
Deficiency of aromatic-L-amino-acid decarboxylase |
• AADC deficiency • Aromatic l-amino acid decarboxylase deficiency • aromatic L-amino acid decarboxylase deficiency • aromatic amino acid decarboxylase deficiency • DDC deficiency • DOPA decarboxylase deficiency |
Metabolic disorders |
DDC dopa decarboxylase |
Reports Updated as of Feb 01, 2025 |
PubMed |
Deficiency of hyaluronoglucosaminidase |
• Mucopolysaccharidosis type 9 • Hyaluronidase deficiency • MPS9 • MPSIX • mucopolysaccharidosis type IX • MPS IX |
Metabolic disorders/Lysosomal storage disorders |
HYAL1 hyaluronidase 1 |
Reports Updated as of Feb 01, 2025 |
PubMed |
Mucopolysaccharidosis type 7 |
• GUSB deficiency • beta-glucuronidase deficiency • deficiency of beta-glucuronidase • MPS VII - Sly syndrome • MPS7 • MPSVII • mucopolysaccharidosis type vii • mucopolysaccharidosis VII • mucopolysaccharidosis, mps-VII • Sly disease • Sly syndrome |
Metabolic disorders/Lysosomal storage disorders |
GUSB glucuronidase beta |
Reports Updated as of Feb 01, 2025 |
PubMed |
Mucopolysaccharidosis, MPS-III-A |
• Heparan sulfate sulfatase deficiency • Sulfamidase deficiency • Sanfilippo syndrome A • Mucopolysaccharidosis type IIIA (Sanfilippo A) • mucopolysaccharidosis type iii • mucopolysaccharidosis, MPS-III • N-sulphoglucosamine sulphohydrolase deficiency • Sanfilippo disease • Sanfilippo syndrome A |
Metabolic disorders/Lysosomal storage disorders |
SGSH N-sulfoglucosamine sulfohydrolase GNPTAB N-acetylglucosamine-1-phosphate transferase subunits alpha and beta |
Reports Updated as of Feb 01, 2025 |
PubMed |
Congenital lipoid adrenal hyperplasia due to STAR deficency |
• Congenital lipoid adrenal hyperplasia • Adrenal hyperplasia I • Cholesterol desmolase-deficient congenital adrenal hyperplasia • CLAH • Cholesterol monooxygenase (side-chain cleaving) deficiency • Lipoid CAH • Lipoid adrenal hyperplasia • Lipoid hyperplasia congenital of adrenal cortex with male pseudohermaphroditism |
Metabolic disorders |
STAR steroidogenic acute regulatory protein |
Reports Updated as of Feb 01, 2025 |
PubMed |
Microcephaly 5, primary, autosomal recessive |
• ASPM autosomal recessive primary microcephaly • autosomal recessive primary microcephaly caused by mutation in ASPM |
Neurodevelopmental disorders |
ASPM assembly factor for spindle microtubules |
Reports Updated as of Feb 01, 2025 |
PubMed |
Combined immunodeficiency due to DOCK8 deficiency |
• Hyper-IgE recurrent infection syndrome, autosomal recessive • Cid due to DOCK8 deficiency • combined immunodeficiency due to dedicator of cytokinesis 8 protein deficiency • dedicator of cytokinesis 8 deficiency • DOCK8 immunodeficiency syndrome • Dock8 deficiency • HIES autosomal recessive • Hyper-IgE recurrent infection syndrome 2, autosomal recessive • Hyper-IgE syndrome 2, autosomal recessive, with recurrent infections |
Immune disorders |
DOCK8 dedicator of cytokinesis 8 |
Reports Updated as of Feb 01, 2025 |
PubMed |
Distal arthrogryposis type 5D |
• ECEL1 distal arthrogryposis • distal arthrogryposis caused by mutation in ECEL1 • distal arthrogryposis type 5 without ophthalmoparesis • distal arthrogryposis type 5 without ophthalmoplegia • DA5D |
Neuromuscular disorders |
ECEL1 endothelin converting enzyme like 1 |
Reports Updated as of Feb 01, 2025 |
PubMed |
Asphyxiating thoracic dystrophy 3 |
• Polydactyly with neonatal chondrodystrophy type 1 • Polydactyly with neonatal chondrodystrophy type III • short-rib thoracic dysplasia 3/6 with polydactyly, digenic • SRPS type 1 • SRPS type 3 • Saldino-Noonan syndrome • short rib polydactyly syndrome, Verma-Naumoff Type • short rib polydactyly syndrome 2B • short rib-polydactyly syndrome type 3 • short rib-polydactyly syndrome Saldino-Noonan type • short rib-polydactyly syndrome type 1 • short-rib polydactyly syndrome type I • short-rib polydactyly syndrome type III • short-rib thoracic dysplasia 3 with or without polydactyly • Verma Naumoff syndrome |
Bone disorders |
DYNC2H1 dynein cytoplasmic 2 heavy chain 1 NEK1 NIMA related kinase 1 DYNLT2B dynein light chain Tctex-type 2B BBS10 Bardet-Biedl syndrome 10 TMEM256 transmembrane protein 256 FAM98C family with sequence similarity 98 member C DYNC2I1 dynein 2 intermediate chain 1 DYNC2I2 dynein 2 intermediate chain 2 KIF24 kinesin family member 24 |
Reports Updated as of Feb 01, 2025 |
PubMed |
Chédiak-Higashi syndrome |
• Chediak-Higashi syndrome • Chédiak-Higashi-Steinbrink syndrome |
Immune disorders |
LYST lysosomal trafficking regulator |
Reports Updated as of Feb 01, 2025 |
PubMed |
Epidermolysis bullosa simplex 5B, with muscular dystrophy |
• Epidermolysa bullosa simplex and limb girdle muscular dystrophy • EBS-MD • epidermolysis bullosa simplex and limb-girdle muscular dystrophy • epidermolysis bullosa simplex with muscular dystrophy • limb-girdle muscular dystrophy with epidermolysis bullosa simplex |
Skin disorders |
PLEC plectin |
Reports Updated as of Feb 01, 2025 |
PubMed |
Epidermolysis bullosa simplex 5C, with pyloric atresia |
• epidermolysis bullosa simplex with pyloric atresia • EBS-PA • PLEC-Related epidermolysis bullosa with pyloric atresia • PLEC1-Related epidermolysis bullosa with pyloric atresia |
Skin disorders |
PLEC plectin |
Reports Updated as of Feb 01, 2025 |
PubMed |
Epidermolysis bullosa simplex with nail dystrophy | Skin disorders |
PLEC plectin |
Reports Updated as of Feb 01, 2025 |
PubMed | |
Very long chain acyl-CoA dehydrogenase deficiency |
• VLCAD Deficiency • acyl-CoA dehydrogenase, very long-chain deficiency • very long-chain acyl-CoA dehydrogenase deficiency • very long-chain acyl-Coenzyme A dehydrogenase deficiency • VLCAD |
Metabolic disorders |
ACADVL acyl-CoA dehydrogenase very long chain ACADL acyl-CoA dehydrogenase long chain |
Reports Updated as of Feb 01, 2025 |
PubMed |
Lethal congenital contracture syndrome 9 | Neuromuscular disorders |
ADGRG6 adhesion G protein-coupled receptor G6 |
Reports Updated as of Feb 01, 2025 |
PubMed | |
Sjögren-Larsson syndrome |
• Fatty acid alcohol oxidoreductase deficiency • Senior-Løken Syndrome • Sjogren Larsson syndrome • Sjogren-Larsson's syndrome • Fatty alcohol:NAD+ oxidoreductase deficiency • Fatty aldehyde dehydrogenase deficiency • Ichthyosis, spastic neurologic disorder, and oligophrenia • FADH deficiency • FAO deficiency • Sjogren-Larsson syndrome |
Metabolic disorders |
ALDH3A2 aldehyde dehydrogenase 3 family member A2 |
Reports Updated as of Feb 01, 2025 |
PubMed |
Spinal muscular atrophy-progressive myoclonic epilepsy syndrome |
• Jankovic-Rivera syndrome • hereditary myoclonus-progressive distal muscular atrophy syndrome • hereditary myoclonus and progressive distal muscular atrophy • Spinal muscular atrophy with progressive myoclonic epilepsy • Jankovic Rivera syndrome |
Neuromuscular disorders |
ASAH1 N-acylsphingosine amidohydrolase 1 |
Reports Updated as of Feb 01, 2025 |
PubMed |
Autosomal recessive multiple pterygium syndrome |
• Autosomal recessive multiple pterygium syndrome • Escobar syndrome • Pterygium Colli syndrome • autosomal recessive non-lethal multiple pterygium syndrome • Escobar variant multiple pterygium syndrome • Multiple pterygium syndrome Escobar type • Multiple pterygium syndrome nonlethal type |
Multisystemic disorders |
CHRNG cholinergic receptor nicotinic gamma subunit CHRNA1 cholinergic receptor nicotinic alpha 1 subunit |
Reports Updated as of Feb 01, 2025 |
PubMed |
Lethal multiple pterygium syndrome | Multisystemic disorders |
CHRND cholinergic receptor nicotinic delta subunit CHRNA1 cholinergic receptor nicotinic alpha 1 subunit CHRNG cholinergic receptor nicotinic gamma subunit |
Reports Updated as of Feb 01, 2025 |
PubMed | |
Giant axonal neuropathy 1 |
• gan giant axonal neuropathy • giant axonal neuropathy caused by mutation in gan • giant axonal neuropathy type 1 • giant axonal neuropathy-1 • giant axonal neuropathy 1, autosomal recessive |
Neurodegenerative disorders |
GAN gigaxonin |
Reports Updated as of Feb 01, 2025 |
PubMed |
Hereditary insensitivity to pain with anhidrosis |
• Hereditary sensory and autonomic neuropathy type 4 • CIP-anhidrosis syndrome • HSAN4 • congenital insensitivity to pain with anhidrosis • congenital insensitivity to pain-anhidrosis syndrome • hereditary sensory and autonomic neuropathy caused by mutation in NTRK1 • hereditary sensory and autonomic neuropathy type iv • hereditary sensory neuropathy type IV • insensitivity to pain, congenital, with anhidrosis • NTRK1 hereditary sensory and autonomic neuropathy • Familial dysautonomia, type 2 • Neuropathy, congenital sensory, with anhidrosis |
Neuronal disorders |
NTRK1 neurotrophic receptor tyrosine kinase 1 |
Reports Updated as of Feb 01, 2025 |
PubMed |
Familial dysautonomia |
• Riley-day syndrome • dysautonomia, familial • familial dysautonomia • hereditary sensory and autonomic neuropathy 3 • hereditary sensory and autonomic neuropathy type 3 • hereditary sensory and autonomic neuropathy type III • hereditary sensory neuropathy type 3 • HSAN 3 • HSAN III • HSAN3 • HSN 3 • neuropathy, hereditary sensory and autonomic, type 3 • neuropathy, hereditary sensory and autonomic, type III • Riley Day syndrome • FD |
Neuromuscular disorders |
ELP1 elongator acetyltransferase complex subunit 1 |
Reports Updated as of Feb 01, 2025 |
PubMed |
Eichsfeld type congenital muscular dystrophy |
• Rigid spine muscular dystrophy 1 • Congenital myopathy 3 with rigid spine • Myopathy, sepn1-related |
Neuromuscular disorders |
SELENON selenoprotein N |
Reports Updated as of Feb 01, 2025 |
PubMed |
Jervell and Lange-Nielsen syndrome |
• Jervell-Lange Nielsen syndrome • Jervell and Lange Nielsen syndrome • long QT interval-deafness syndrome |
Multisystemic disorders |
KCNQ1 potassium voltage-gated channel subfamily Q member 1 KCNE1 potassium voltage-gated channel subfamily E regulatory subunit 1 |
Reports Updated as of Feb 01, 2025 |
PubMed |
Renal carnitine transport defect |
• Systemic primary carnitine deficiency disease • Carnitine deficiency • Carnitine transporter defect • carnitine transporter deficiency • carnitine uptake defect • Carnitine uptake deficiency • CDSP • cud • deficiency of plasma-membrane carnitine transporter • primary carnitine deficiency • renal carnitine transport defect • SPCD • carnitine deficiency, systemic, due to defect in renal reabsorption of carnitine • carnitine plasma-membrane transporter deficiency • Systemic primary carnitine deficiency |
Metabolic disorders |
SLC22A5 solute carrier family 22 member 5 |
Reports Updated as of Feb 01, 2025 |
PubMed |
Carnitine acylcarnitine translocase deficiency |
• Carnitine-acylcarnitine translocase deficiency • cact deficiency |
Metabolic disorders |
SLC25A20 solute carrier family 25 member 20 |
Reports Updated as of Feb 01, 2025 |
PubMed |
Pontocerebellar hypoplasia type 9 |
• AMPD2 non-syndromic pontocerebellar hypoplasia • non-syndromic pontocerebellar hypoplasia caused by mutation in AMPD2 • PCH9 |
Neuromuscular disorders |
AMPD2 adenosine monophosphate deaminase 2 |
Reports Updated as of Feb 01, 2025 |
PubMed |
Brown-Vialetto-van Laere syndrome 2 |
• Riboflavin transporter deficiency type 2 |
Neuromuscular disorders |
SLC52A2 solute carrier family 52 member 2 |
Reports Updated as of Feb 01, 2025 |
PubMed |
Myoglobinuria, acute recurrent, autosomal recessive |
• myoglobinuria, familial paroxysmal paralytic • myoglobinuria, recurrent, autosomal recessive • rhabdomyolysis, acute recurrent |
Metabolic disorders |
LPIN1 lipin 1 |
Reports Updated as of Feb 01, 2025 |
PubMed |
Charlevoix-Saguenay spastic ataxia |
• autosomal recessive spastic ataxia type 6 • ARSACS • SPAX6 • autosomal recessive spastic ataxia of Charlevoix-Saguenay • spastic ataxia 6, autosomal recessive • spastic ataxia of Charlevoix-Saguenay |
Neurodegenerative disorders |
SACS sacsin molecular chaperone |
Reports Updated as of Feb 01, 2025 |
PubMed |
Congenital generalized lipodystrophy type 1 |
• AGPAT2 congenital generalised lipodystrophy (disease) • AGPAT2 congenital generalized lipodystrophy (disease) • Berardinelli-Seip congenital lipodystrophy, type 1 • Brunzell syndrome AGPAT2-related • BSCL1 • CGL1 • congenital generalised lipodystrophy (disease) caused by mutation in AGPAT2 • congenital generalized lipodystrophy (disease) caused by mutation in AGPAT2 |
Metabolic disorders |
AGPAT2 1-acylglycerol-3-phosphate O-acyltransferase 2 |
Reports Updated as of Feb 01, 2025 |
PubMed |
Klippel-Feil syndrome 2, autosomal recessive |
• Cervical vertebral fusion, autosomal recessive • KFS, autosomal recessive • Klippel-Feil syndrome 2 • Klippel Feil syndrome autosomal recessive |
Bone disorders |
MEOX1 mesenchyme homeobox 1 |
Reports Updated as of Feb 01, 2025 |
PubMed |
Agenesis of the corpus callosum with peripheral neuropathy |
• Andermann syndrome • Charlevoix disease • corpus callosum agenesis-neuronopathy syndrome • hereditary motor and sensory neuropathy with agenesis of the corpus callosum • peripheral neuropathy associated with agenesis of the corpus callosum • Agenesis of corpus callosum with neuronopathy • Agenesis of corpus callosum with peripheral neuropathy • Agenesis of corpus callosum with polyneuropathy • Corpus callosum agenesis neuronopathy • Hmsn/acc • Hereditary motor and sensory neuropathy with agenesis of the corpus callosum • Polyneuropathy, sensorimotor, with or without agenesis of the corpus callosum |
Neurodegenerative disorders |
SLC12A6 solute carrier family 12 member 6 |
Reports Updated as of Feb 01, 2025 |
PubMed |
Fetal akinesia deformation sequence 3 |
• DOK7-Related Fetal Akinesia Deformation Sequence |
Respiratory disorders |
DOK7 docking protein 7 DOCK7 dedicator of cytokinesis 7 |
Reports Updated as of Feb 01, 2025 |
PubMed |
Fetal akinesia deformation sequence 1 |
• Lethal Pena-Shokeir 1 syndrome • Arthrogryposis multiplex congenita-pulmonary hypoplasia syndrome • Fetal akinesia sequence • Pena Shokeir syndrome, type 1 • Pena-Shokeir syndrome type I |
Respiratory disorders |
MUSK muscle associated receptor tyrosine kinase DOK7 docking protein 7 RAPSN receptor associated protein of the synapse ASCC1 activating signal cointegrator 1 complex subunit 1 VPS13D vacuolar protein sorting 13 homolog D ASPM assembly factor for spindle microtubules CHRNG cholinergic receptor nicotinic gamma subunit ASAH1 N-acylsphingosine amidohydrolase 1 ADSS1 adenylosuccinate synthase 1 EARS2 glutamyl-tRNA synthetase 2, mitochondrial LGI4 leucine rich repeat LGI family member 4 RYR1 ryanodine receptor 1 GLDN gliomedin |
Reports Updated as of Feb 01, 2025 |
PubMed |
Pyruvate kinase deficiency of red cells |
• Hemolytic anemia due to red cell pyruvate kinase deficiency • hemolytic anaemia due to red cell pyruvate kinase deficiency • hemolytic Anemia due to pyruvate Kinase deficiency • hemolytic anemia due to red cell pyruvate kinase deficiency • pyruvate kinase deficiency of erythrocytes • PK deficiency • Pyruvate kinase deficiency of erythrocyte • Pyruvate kinase deficiency • Pyruvate kinase deficiency of erythrocytes • Pyruvate kinase deficiency,amish type |
Metabolic disorders |
PKLR pyruvate kinase L/R |
Reports Updated as of Feb 01, 2025 |
PubMed |
Fibrosis of extraocular muscles, congenital, 2 |
• PHOX2A-related congenital fibrosis of the extraocular muscles • congenital fibrosis of the extraocular muscles 2 • FEOM2 locus • fibrosis of extraocular muscles, congenital, autosomal recessive |
Neuromuscular disorders |
PHOX2A paired like homeobox 2A |
Reports Updated as of Feb 01, 2025 |
PubMed |
Infantile neuroaxonal dystrophy |
• Neurodegeneration with brain iron accumulation 2a • Seitelberger disease • inaD • infantile neuroaxonal dystrophy 1 • NBIA2A • neurodegeneration with brain iron accumulation type 2a • neurodegeneration, pla2g6-associated • phospholipase A2-associated neurodegeneration • PLAN |
Neurodegenerative disorders |
PLA2G6 phospholipase A2 group VI |
Reports Updated as of Feb 01, 2025 |
PubMed |
Glycogen storage disease, type V |
• Mcardle disease • glycogen storage disease caused by mutation in PYGM • glycogen storage disease type 5 • glycogen storage disease type V • glycogen storage disease, type V • glycogenosis due to muscle glycogen phosphorylase deficiency • glycogenosis type 5 • glycogenosis type V • GSD due to muscle glycogen phosphorylase deficiency • GSD type 5 • GSD type V • McArdle's disease • myophosphorylase deficiency • PYGM glycogen storage disease • GSD 5 • muscle glycogen phosphorylase deficiency • McArdle type glycogen storage disease • pygm deficiency |
Metabolic disorders |
PFKM phosphofructokinase, muscle PYGM glycogen phosphorylase, muscle associated PYGL glycogen phosphorylase L |
Reports Updated as of Feb 01, 2025 |
PubMed |
Myopathy, lactic acidosis, and sideroblastic anemia 1 | Metabolic disorders |
PUS1 pseudouridine synthase 1 |
Reports Updated as of Feb 01, 2025 |
PubMed | |
Cerebellar ataxia-hypogonadism syndrome |
• Gordon-Holmes syndrome • luteinizing hormone-releasing hormone deficiency with ataxia • Cerebellar ataxia hypogonadotropic hypogonadism • Gordon Holmes syndrome • Lhrh deficiency and ataxia • Luteinizing hormone releasing hormone, deficiency of with ataxia |
Multisystemic disorders |
RNF216 ring finger protein 216 |
Reports Updated as of Feb 01, 2025 |
PubMed |
Marinesco-Sjögren syndrome |
• Oligophrenic cerebellolenticular degeneration • Garland-Moorhouse syndrome • hereditary oligophrenic cerebello-lental degeneration • Marinesco-Garland syndrome • Marshall Smith Syndrome • Marinesco-Sjogren Syndrome • Marinesco-Sjogren Syndrome-Hypergonadotrophic Hypogonadism • Marinesco-Sjogren Syndrome-Myopathy • Marinesco-Sjogren-Garland Syndrome • Marinesco-Sjögren syndrome |
Neurodegenerative disorders |
SIL1 SIL1 nucleotide exchange factor |
Reports Updated as of Feb 01, 2025 |
PubMed |
Imerslund-Grasbeck syndrome type 1 |
• Selective cobalamin malabsorption with proteinuria • Enterocyte cobalamin malabsorption • Gräsbeck-imerslund disease • Imerslund-Gräsbeck syndrome • Defect of enterocyte intrinsic factor receptor • Juvenile pernicious anemia with proteinuria due to selective intestinal malabsorption of vitamin B12 • Megaloblastic anemia 1 • Familial megaloblastic anaemia • Familial megaloblastic anemia • Juvenile megaloblastic Anemia • Selective cobalamin malabsorption with proteinuria |
Metabolic disorders |
CUBN cubilin |
Reports Updated as of Feb 04, 2025 |
PubMed |
Merosin deficient congenital muscular dystrophy |
• Congenital merosin-deficient muscular dystrophy 1A • Muscular dystrophy congenital, merosin negative • CMD1A • congenital merosin-deficient muscular dystrophy type 1A • congenital muscular dystrophy caused by mutation in LAMA2 • congenital muscular dystrophy due to laminin alpha2 deficiency • LAMA2 congenital muscular dystrophy • MDC1A • merosin-deficient congenital muscular dystrophy type 1A • merosin-negative congenital muscular dystrophy • muscular dystrophy, congenital merosin-deficient, type 1A • muscular dystrophy, congenital, merosin deficient or partially deficient |
Neuromuscular disorders |
LAMA2 laminin subunit alpha 2 |
Reports Updated as of Feb 04, 2025 |
PubMed |
Grebe syndrome |
• Acromesomelic dysplasia 2a • acromesomelic dysplasia, Grebe type • chondrodysplasia, Grebe type • Grebe chondrodysplasia • Grebe dysplasia • Langer-Saldino achondrogenesis • type II achondrogenesis • Brazilian achondrogenesis |
Bone disorders |
GDF5 growth differentiation factor 5 |
Reports Updated as of Feb 04, 2025 |
PubMed |
Yunis-Varon syndrome |
• Cleidocranial dysplasia with micrognathia, absent thumbs, and distal aphalangia • cleidocranial dysplasia-micrognathia-absent thumbs syndrome • Yunis Varon syndrome • Yunis-Varón syndrome • Cleidocranial dysplasia, micrognathia, absent thumbs, & distal aphalangia |
Bone disorders |
FIG4 FIG4 phosphoinositide 5-phosphatase VAC14 VAC14 component of PIKFYVE complex |
Reports Updated as of Feb 04, 2025 |
PubMed |
Microcephaly, normal intelligence and immunodeficiency |
• Nijmegen breakage syndrome • Ataxia-telangiectasia, variant 1 • Berlin breakage syndrome • immunodeficiency-microcephaly-chromosomal instability syndrome • microcephaly-immunodeficiency-lymphoreticuloma syndrome • microcephaly, normal intelligence and immunodeficiency • Seemanova syndrome • Seemanova syndrome type 2 • Ataxia telangiectasia variant v1 • Immunodeficiency, microcephaly, and chromosomal instability • Immunodeficiency, microcephaly with normal intelligence • Microcephaly with normal intelligence immunodeficiency and lymphoreticular malignancies • Nonsyndromal microcephaly autosomal recessive with normal intelligence • AT V1 |
Immune disorders |
NBN nibrin |
Reports Updated as of Feb 26, 2025 |
PubMed |
Ichthyosis linearis circumflexa |
• - |
Skin disorders |
SPINK5 serine peptidase inhibitor Kazal type 5 |
Reports Updated as of Feb 26, 2025 |
PubMed |
LAMA2-related muscular dystrophy |
• Congenital merosin-deficient muscular dystrophy 1A • LAMA2 congenital muscular dystrophy • congenital merosin-deficient muscular dystrophy type 1A • congenital muscular dystrophy caused by mutation in LAMA2 • congenital muscular dystrophy due to laminin alpha2 deficiency • merosin-deficient congenital muscular dystrophy type 1A • merosin-negative congenital muscular dystrophy • muscular dystrophy, congenital merosin-deficient, type 1A • muscular dystrophy, congenital, merosin deficient or partially deficient • Laminin Alpha-2 Deficiency • Laminin alpha 2-related dystrophy • Merosin deficient congenital muscular dystrophy • Congenital merosin-deficient muscular dystrophy 1A • Muscular dystrophy congenital, merosin negative • CMD1A • MDC1A |
Neuromuscular disorders |
LAMA2 laminin subunit alpha 2 |
Reports Updated as of Feb 26, 2025 |
PubMed |
Hypotonia, infantile, with psychomotor retardation and characteristic facies 1 |
• - |
Neurodevelopmental disorders |
NALCN sodium leak channel, non-selective |
Reports Updated as of Feb 26, 2025 |
PubMed |
Meckel syndrome, type 4 |
• CEP290-Related Meckel Syndrome • Meckel-Gruber syndrome, type 4 |
Multisystemic disorders |
CEP290 centrosomal protein 290 TMEM218 transmembrane protein 218 |
Reports Updated as of Feb 26, 2025 |
PubMed |
Galactosylceramide beta-galactosidase deficiency |
• Krabbe disease • Beta galactocerebrosidase deficiency • Diffuse globoid body sclerosis • galactocerebrosidase deficiency • galactosylceramidase deficiency • galactosylceramide lipidosis • GALC deficiency • globoid cell leukodystrophy • globoid cell leukoencephalopathy • Krabbe's disease • Krabbe's leukodystrophy • Leukodystrophy, Krabbe's • Krabbe leukodystrophy • Leukodystrophy, globoid cell |
Metabolic disorders |
GALC galactosylceramidase PSAP prosaposin |
Reports Updated as of Feb 26, 2025 |
PubMed |
Autosomal recessive hyper-IgE syndrome |
• Autosomal recessive hyper-IgE syndrome due to ZNF341 deficiency |
Immune disorders |
DOCK8 dedicator of cytokinesis 8 |
Reports Updated as of Feb 26, 2025 |
PubMed |
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A1 |
• Cerebroocular dysgenesis • Chemke syndrome • COD-MD syndrome • Cerebroocular dysplasia muscular dystrophy syndrome • Hard +/- E syndrome • Hydrocephalus, agyria and retinal dysplasia • Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 1 • Pagon syndrome • WALKER-WARBURG SYNDROME OR MUSCLE-EYE-BRAIN DISEASE, POMT1-RELATED • Warburg syndrome |
Multisystemic disorders |
POMT1 protein O-mannosyltransferase 1 |
Reports Updated as of Feb 26, 2025 |
PubMed |
Autosomal recessive limb-girdle muscular dystrophy type 2A |
• Calpainopathy • Leyden-Moebius muscular dystrophy • autosomal recessive limb-girdle muscular dystrophy caused by mutation in CAPN3 • CAPN3 autosomal recessive limb-girdle muscular dystrophy • limb-girdle muscular dystrophy due to calpain deficiency • limb-girdle muscular dystrophy type 2A • muscular dystrophy, limb-girdle, autosomal recessive 1 • muscular dystrophy, limb-girdle, type 2A • pelvofemoral muscular dystrophy • primary calpainopathy • LGMD2A |
Neuromuscular disorders |
CAPN3 calpain 3 |
Reports Updated as of Feb 26, 2025 |
PubMed |
Mucopolysaccharidosis type 1 |
• Alpha-L-iduronidase deficiency • iduronidase deficiency disease • lipochondrodystrophy • MPS I - Hurler syndrome • MPS1 • MPSI • mucopolysaccharidosis type i • mucopolysaccharidosis, MPS-I • mucopolysaccharidosis, type 1 • Attenuated MPS I (subtype) • Hurler-Scheie syndrome (former subtype) • IDUA deficiency • Mucopolysaccharidosis Type I • Scheie syndrome (former subtype • formerly known as Mucopoly-saccharidosis type V) • Severe MPS I (subtype) |
Metabolic disorders/Lysosomal storage disorders |
IDUA alpha-L-iduronidase |
Reports Updated as of Feb 26, 2025 |
PubMed |
ALG1-congenital disorder of glycosylation |
• Carbohydrate deficient glycoprotein syndrome type Ik • CDG syndrome type Ik • congenital disorder of glycosylation type 1k • congenital disorder of glycosylation type Ik • mannosyltransferase 1 deficiency • CDG-Ik • CDG1K • ALG1-CDG • ALG1-CDG (CDG-Ik) • CDG 1K • CDG Ik |
Metabolic disorders |
ALG1 ALG1 chitobiosyldiphosphodolichol beta-mannosyltransferase |
Reports Updated as of Feb 26, 2025 |
PubMed |
Progressive sclerosing poliodystrophy |
• Mitochondrial dna depletion syndrome 4a • Alper syndrome • Poliodystrophia cerebri progressiva • Progressive cerebral poliodystrophy • Alper's disease • Alper's syndrome • Alpers disease • Alpers Huttenlocher disease • Alpers Huttenlocher syndrome • Alpers progressive infantile poliodystrophy • Alpers progressive sclerosing poliodystrophy • Alpers syndrome • Alpers-Huttenlocher syndrome • Alpers disease or gray-matter degeneration • mitochondrial DNA depletion syndrome type 4a • progressive neuronal degeneration of childhood with liver disease • Alpers diffuse degeneration of cerebral gray matter with hepatic cirrhosis • Alpers-Huttenlocher Syndrome • Diffuse cerebral degeneration in infancy • Infantile poliodystrophy • Mitochondrial DNA depletion syndrome 4A (Alpers type) • Neuronal degeneration of childhood with liver disease, progressive • AHD • AHS |
Neurodegenerative disorders |
POLG DNA polymerase gamma, catalytic subunit EDAR ectodysplasin A receptor |
Reports Updated as of Feb 26, 2025 |
PubMed |
Congenital hypotrichosis with juvenile macular dystrophy |
• Hypotrichosis with cone-rod dystrophy • hypotrichosis with juvenile macular dystrophy • Juvenile macular degeneration and hypotrichosis • Juvenile macular dystrophy and congenital hypotrichosis • hjmd |
Hair disorders |
CDH3 cadherin 3 |
Reports Updated as of Feb 26, 2025 |
PubMed |
Homocystinuria due to methylene tetrahydrofolate reductase deficiency |
• methylene tetrahydrofolate reductase deficiency • MTHFR deficiency • Methylenetetrahydro-folate reductase deficiency • 5,10-alpha-methylenetetrahydro-folate reductase deficiency • Homocysteinuria due to mthfr deficiency • Homocystinuria due to deficiency of n(5,10)-methylenetetrahydrofolate reductase activity • Homocysteinemia due to mthfr deficiency • Homocysteinemia due to methylenetetrahydro-folate reductase deficiency • Homocysteinuria due to methylenetetrahydro-folate reductase deficiency • Homocystinuria due to mthfr deficiency |
Metabolic disorders/Lysosomal storage disorders |
MTHFR methylenetetrahydrofolate reductase |
Reports Updated as of Feb 26, 2025 |
PubMed |
Cerebrooculofacioskeletal syndrome 2 | Multisystemic disorders |
ERCC2 ERCC excision repair 2, TFIIH core complex helicase subunit |
Reports Updated as of Feb 26, 2025 |
PubMed | |
Glycogen storage disease, type VII |
• Glycogen storage disease caused by mutation in PFKM • Tarui disease • Muscle phosphofructokinase deficiency • glycogen storage disease type 7 • glycogen storage disease type VII • glycogen storage disease, type VII • glycogenosis due to muscle phosphofructokinase deficiency • glycogenosis type 7 • glycogenosis type VII • GSD due to muscle phosphofructokinase deficiency • PFKM glycogen storage disease • phosphofructokinase deficiency • phosphofructokinase myopathy • GSD type 7 • GSD type VII • GSDVII • Pfkm deficiency |
Metabolic disorders |
PFKM phosphofructokinase, muscle |
Reports Updated as of Feb 26, 2025 |
PubMed |
Severe early-childhood-onset retinal dystrophy |
• Stargardt disease 1 • Juvenile onset macular degeneration • early-onset severe retinal dystrophy • ABCA4-Related Stargardt Disease 1 • CNGB3-Related Stargardt Disease 1 • Stargardt macular dystrophy • Macular dystrophy with flecks, type 1 • STGD • EOSRD • SECORD |
Eye disorders |
CNGB3 cyclic nucleotide gated channel subunit beta 3 ABCA4 ATP binding cassette subfamily A member 4 |
Reports Updated as of Feb 26, 2025 |
PubMed |